Skip to content

GLP-1 price check, Sep 30, 2026

We re-read 3,223 official sentences on 861 pages. 2,999 were still there, word for word. 20 could not be found and go back to a person to re-read. 204 were on pages that would not load. 219 come from official Word, Excel or PDF files, which this check does not download; they keep the date they were last read.

What changed

  • Page did not load: 2.5 mg/0.5 mL (starting dosage) Self-pay price: Starting at $299/month* lilly.com Used for: LillyDirect: zepbound injection-vial 2.5 mg; Savings check: zepbound with uninsured; Article: compounded-vs-brand-glp-1-price; Article: glp-1-statistics; Article: hims-hers-glp-1-cost; Review: eden; Review: hims-hers; Review: lemonaid-health; Review: lifemd; Review: lillydirect
  • Page did not load: 5 mg/0.5 mL Self-pay price: Starting at $399/month* lilly.com Used for: LillyDirect: zepbound injection-vial 5 mg; Review: lillydirect
  • Page did not load: 7.5 mg/0.5 mL Self-pay price: Starting at $449/month* when you refill within 45 days† lilly.com Used for: LillyDirect: zepbound injection-vial 7.5 mg; Review: lillydirect
  • Page did not load: 10 mg/0.5 mL Self-pay price: Starting at $449/month* when you refill within 45 days† lilly.com Used for: LillyDirect: zepbound injection-vial 10 mg
  • Page did not load: 12.5 mg/0.5 mL Self-pay price: Starting at $449/month* when you refill within 45 days† lilly.com Used for: LillyDirect: zepbound injection-vial 12.5 mg
  • Page did not load: 15 mg/0.5 mL Self-pay price: Starting at $449/month* when you refill within 45 days† lilly.com Used for: LillyDirect: zepbound injection-vial 15 mg; Article: compounded-vs-brand-glp-1-price; Article: glp-1-statistics
  • Page did not load: Month is defined as 28-days and 4 single-dose vials lilly.com Used for: LillyDirect: zepbound injection-vial fill length; Review: lillydirect
  • Page did not load: Exclusively available through LillyDirect | Self-pay only lilly.com Used for: LillyDirect: zepbound injection-vial insurance; Savings check: zepbound with uninsured
  • Page did not load: 2.5 mg/0.6 mL (starting dosage) Self-pay price: Starting at $299/month* lilly.com Used for: LillyDirect: zepbound injection-pen 2.5 mg; Article: glp-1-price-changes-2026; Article: insurance-dropped-glp-1-coverage; Article: trumprx-with-insurance-or-medicare; Article: wegovy-vs-zepbound-5-year-cost; Article: zepbound-patient-assistance; Review: lillydirect; Review: plushcare
  • Page did not load: 5 mg/0.6 mL Self-pay price: Starting at $399/month* lilly.com Used for: LillyDirect: zepbound injection-pen 5 mg; Article: glp-1-price-changes-2026; Article: wegovy-vs-zepbound-5-year-cost; Article: zepbound-patient-assistance
  • Page did not load: 7.5 mg/0.6 mL Self-pay price: Starting at $449/month* when you refill within 45 days† lilly.com Used for: LillyDirect: zepbound injection-pen 7.5 mg; Review: sesame
  • Page did not load: 10 mg/0.6 mL Self-pay price: Starting at $449/month* when you refill within 45 days† lilly.com Used for: LillyDirect: zepbound injection-pen 10 mg
  • Page did not load: 12.5 mg/0.6 mL Self-pay price: Starting at $449/month* when you refill within 45 days† lilly.com Used for: LillyDirect: zepbound injection-pen 12.5 mg
  • Page did not load: 15 mg/0.6 mL Self-pay price: Starting at $449/month* when you refill within 45 days† lilly.com Used for: LillyDirect: zepbound injection-pen 15 mg; Review: effecty; Review: fridays; Review: gobymeds; Review: goodrx-weight-loss; Review: maximus-tribe; Review: orderlymeds
  • Page did not load: Month is defined as 28-days and 1 single-patient-use KwikPen lilly.com Used for: LillyDirect: zepbound injection-pen fill length
  • Page did not load: 0.8 mg dose (starting dosage) Self-pay price: Starting at $149/month^ lilly.com Used for: LillyDirect: foundayo pill 0.8 mg; Savings check: foundayo with uninsured; Article: compounded-vs-brand-glp-1-price; Article: glp-1-statistics; Review: lillydirect; Review: noom-med
  • Page did not load: 2.5 mg dose Self-pay price: Starting at $149/month^* lilly.com Used for: LillyDirect: foundayo pill 2.5 mg
  • Page did not load: 5.5 mg dose Self-pay price: Starting at $199/month^* lilly.com Used for: LillyDirect: foundayo pill 5.5 mg; Review: lillydirect
  • Page did not load: 9 mg dose Self-pay price: Starting at $299/month^ lilly.com Used for: LillyDirect: foundayo pill 9 mg; Review: lillydirect
  • Page did not load: 14.5 mg dose Self-pay price: Starting at $299/month^ when you refill within 45 days† lilly.com Used for: LillyDirect: foundayo pill 14.5 mg
  • Page did not load: 17.2 mg dose Self-pay price: Starting at $299/month^ when you refill within 45 days† lilly.com Used for: LillyDirect: foundayo pill 17.2 mg; Article: compounded-vs-brand-glp-1-price; Article: glp-1-statistics
  • Page did not load: Month is defined as 30-days lilly.com Used for: LillyDirect: foundayo pill fill length
  • Page did not load: 2.5 mg/0.5 mL Self-pay price: Starting at $499/month* lilly.com Used for: LillyDirect: mounjaro injection-pen 2.5 mg; Savings check: mounjaro with uninsured; Article: mounjaro-patient-assistance
  • Page did not load: 5 mg/0.5 mL Self-pay price: Starting at $499/month* lilly.com Used for: LillyDirect: mounjaro injection-pen 5 mg
  • Page did not load: 7.5 mg/0.5 mL Self-pay price: Starting at $499/month* lilly.com Used for: LillyDirect: mounjaro injection-pen 7.5 mg
  • Page did not load: 10 mg/0.5 mL Self-pay price: Starting at $499/month* lilly.com Used for: LillyDirect: mounjaro injection-pen 10 mg
  • Page did not load: 12.5 mg/0.5 mL Self-pay price: Starting at $499/month* lilly.com Used for: LillyDirect: mounjaro injection-pen 12.5 mg
  • Page did not load: 15 mg/0.5 mL Self-pay price: Starting at $499/month* lilly.com Used for: LillyDirect: mounjaro injection-pen 15 mg; Article: mounjaro-patient-assistance
  • Page did not load: $25 for a 1-month, 2-month, or 3-month prescription fill of Zepbound single-dose pen lilly.com Used for: Savings check: zepbound with commercial
  • Page did not load: a separate maximum annual savings of up to $1,300 per calendar year lilly.com Used for: Savings check: zepbound with commercial; Zepbound card: caps; Article: zepbound-patient-assistance
  • Page did not load: Card expires and savings end on 12/31/2026 lilly.com Used for: Savings check: zepbound with commercial
  • Page did not load: You are not enrolled in any state, federal, or government funded healthcare program, including, without limitation, Medicaid, Medicare lilly.com Used for: Savings check: zepbound with medicare; Savings check: zepbound with medicaid; Zepbound card: government; Article: zepbound-patient-assistance
  • Page did not load: You must have commercial drug insurance that covers Foundayo and a prescription for an approved use consistent with FDA-approved product labeling to pay as little as lilly.com Used for: Savings check: foundayo with commercial; Savings check: foundayo with uninsured; Foundayo card: covered
  • Page did not load: a separate maximum annual savings of up to $1,000 per calendar year lilly.com Used for: Savings check: foundayo with commercial; Foundayo card: caps
  • Page did not load: Card expires and savings end on 12/31/2026 lilly.com Used for: Savings check: foundayo with commercial
  • Page did not load: You are not enrolled in any state, federal, or government funded healthcare program, including, without limitation, Medicaid, Medicare lilly.com Used for: Savings check: foundayo with medicare; Savings check: foundayo with medicaid; Foundayo card: government
  • Page did not load: You must have commercial drug insurance that covers Zepbound single-dose pen and a prescription for an approved use consistent with FDA-approved product labeling to pay as little as $25 for a 1-month, 2-month, or 3-month prescription fill of Zepbound single-dose pen. lilly.com Used for: Savings check: zepbound with uninsured; Zepbound card: covered; Article: trumprx-with-insurance-or-medicare; Article: zepbound-patient-assistance
  • Page did not load: Pay as low as $299 for your 1-month prescription fill of Zepbound 2.5 mg single-patient-use KwikPen lilly.com Used for: Savings check: zepbound with uninsured; Zepbound card: kwikPenSelfPay
  • Page did not load: Savings may not be applied at the point of sale and may require further action from you to obtain the applicable savings. lilly.com Used for: Savings check: zepbound with uninsured; Zepbound card: pointOfSale
  • Page did not load: You are enrolled in a commercial drug insurance plan; mounjaro.lilly.com Used for: Savings check: mounjaro with uninsured; Mounjaro card: commercialPlan
  • Page did not load: You must have commercial drug insurance that covers Mounjaro® (tirzepatide) and a prescription for an approved use consistent with FDA-approved product labeling to pay as little as $25 for a 1-month, 2-month, or 3-month prescription fill of Mounjaro single-dose pen. mounjaro.lilly.com Used for: Savings check: mounjaro with commercial; Mounjaro card: covered; Article: mounjaro-patient-assistance
  • Page did not load: Card savings are subject to a maximum monthly savings of up to $150 per 1-month prescription, $300 per 2-month prescription, or $450 per 3-month prescription fill and a separate maximum annual savings of up to $1,950 per calendar year. mounjaro.lilly.com Used for: Savings check: mounjaro with commercial; Mounjaro card: coveredCaps; Article: mounjaro-patient-assistance
  • Page did not load: You must have commercial drug insurance that does not cover Mounjaro and a prescription for an approved use consistent with FDA-approved product labeling to pay as low as $499 for a 1-month prescription fill of Mounjaro single-dose pen. mounjaro.lilly.com Used for: Savings check: mounjaro with commercial; Mounjaro card: notCovered; Article: mounjaro-patient-assistance
  • Page did not load: Card may be used for a maximum of up to 13 prescription fills per calendar year. mounjaro.lilly.com Used for: Savings check: mounjaro with commercial; Mounjaro card: fills; Article: mounjaro-patient-assistance
  • Page did not load: Card expires and savings end on 12/31/2026. mounjaro.lilly.com Used for: Savings check: mounjaro with commercial; Mounjaro card: expires; Article: mounjaro-patient-assistance
  • Page did not load: Card savings cannot be combined or utilized with any other program, discount, discount card, cash discount card, coupon, incentive, or similar offer involving Mounjaro. mounjaro.lilly.com Used for: Savings check: mounjaro with commercial; Mounjaro card: noStacking
  • Page did not load: You are not enrolled in any state, federal, or government funded healthcare program, including, without limitation, Medicaid, Medicare, Medicare Part D, Medicare Advantage, Medigap, DoD, VA, TRICARE®/CHAMPUS, or any state prescription drug assistance program; mounjaro.lilly.com Used for: Savings check: mounjaro with medicare; Savings check: mounjaro with medicaid; Mounjaro card: government; Article: mounjaro-patient-assistance
  • Page did not load: Zepbound is an injectable once-weekly prescription medicine that may help adults with obesity to lose weight and keep it off lilly.com Used for: Zepbound: label; Zepbound: injection-vial schedule; Zepbound: injection-pen schedule
  • Page did not load: Foundayo™ (orforglipron) | Once-Daily Weight Management Pill foundayo.lilly.com Used for: Foundayo: label; Foundayo: pill schedule
  • Page did not load: Mounjaro is an injectable prescription medicine that is used: along with diet and exercise to improve blood sugar (glucose) in adults and children 10 years of age and older with type 2 diabetes mellitus. mounjaro.lilly.com Used for: Mounjaro: label; Label: mounjaro; Review: mybmi
  • Page did not load: Mounjaro is not a weight loss drug. mounjaro.lilly.com Used for: Label: mounjaroNotWeight; Article: mounjaro-patient-assistance; Article: what-is-tirzepatide; Review: eden; Review: ivy-rx
  • Page did not load: Card savings are subject to a maximum monthly savings of up to $647 and a separate maximum annual savings of up to $8,411 per calendar year. mounjaro.lilly.com Used for: Mounjaro card: notCoveredCaps; Article: mounjaro-patient-assistance
  • Page did not load: Card savings are available only for Mounjaro prescriptions for the Mounjaro single-dose pen mounjaro.lilly.com Used for: Mounjaro card: penOnly
  • Page did not load: To see If you’re eligible and to download your card, click the “Get Savings Card” button and answer the attestation questions. mounjaro.lilly.com Used for: Mounjaro card: howTo
  • Page did not load: Card activation is required. mounjaro.lilly.com Used for: Mounjaro card: activation
  • Page did not load: Card savings are subject to a maximum monthly savings of up to $100 per 1-month prescription lilly.com Used for: Zepbound card: monthlyCap
  • Page did not load: Card may be used for a maximum of up to 13 prescription fills per calendar year. lilly.com Used for: Zepbound card: fills
  • Page did not load: to pay as low as $499 for your 1-month prescription fill of Zepbound single-dose pen lilly.com Used for: Zepbound card: notCovered; Article: zepbound-patient-assistance
  • Page did not load: You will automatically receive the $449 purchase offer on your first purchase of the 7.5 mg, 10 mg, 12.5 mg, or 15 mg Zepbound single-patient-use KwikPen. lilly.com Used for: Zepbound card: kwikPenHigher
  • Page did not load: you must complete your refill purchase of the Zepbound single-patient-use KwikPen within 45 days of the delivery/received date of your previous Zepbound single-patient-use KwikPen prescription fill. lilly.com Used for: Zepbound card: refillWindow
  • Page did not load: Claims for reimbursement must be submitted in the patient portal or postmarked no later than March 31, 2027. lilly.com Used for: Zepbound card: claimDeadline
  • Page did not load: Card expires and savings end on 12/31/2026. lilly.com Used for: Zepbound card: expires; Article: zepbound-patient-assistance
  • Page did not load: Card activation is required. lilly.com Used for: Zepbound card: activation
  • Page did not load: Card savings are subject to a maximum monthly savings of up to $100 per 1-month prescription lilly.com Used for: Foundayo card: monthlyCap
  • Page did not load: Card may be used for a maximum of up to 10 prescription fills per calendar year. lilly.com Used for: Foundayo card: fills
  • Page did not load: You will automatically receive the $299 purchase offer on your first purchase of the 14.5 mg or 17.2 mg Foundayo dosages. lilly.com Used for: Foundayo card: topDoseOffer
  • Page did not load: you must complete your refill purchase of Foundayo within 45 days of the delivery/received date of your previous Foundayo prescription fill. lilly.com Used for: Foundayo card: refillWindow
  • Page did not load: Savings may not be applied at the point of sale and may require further action from you to obtain the applicable savings. lilly.com Used for: Foundayo card: pointOfSale
  • Page did not load: Card expires and savings end on 12/31/2026. lilly.com Used for: Foundayo card: expires
  • Page did not load: Card activation is required. lilly.com Used for: Foundayo card: activation
  • Page did not load: you may qualify for free Lilly medicine through the Lilly Cares Foundation, a separate nonprofit organization lilly.com Used for: Lilly Cares
  • Page did not load: Present the coupon at your pharmacy to claim your TrumpRx savings. trumprx.gov Used for: TrumpRx: novoCoupon; Article: trumprx-with-insurance-or-medicare
  • Page did not load: By continuing and using this offer, you agree that this offer is for self-pay patients only trumprx.gov Used for: TrumpRx: selfPayOnly; Article: trumprx-with-insurance-or-medicare
  • Page did not load: LillyDirect® will guide you to savings options, eligibility confirmation, and offers delivery options or transfer to a retail pharmacy of your choosing. trumprx.gov Used for: TrumpRx: lillyHandoff; Article: trumprx-with-insurance-or-medicare
  • Page did not load: Original price represents the Wholesale Acquisition Cost trumprx.gov Used for: TrumpRx: listPrice
  • Page did not load: "strength":"2.5","quantity":"1","price":{"trxPrice":29900,"beforePrice":108700} trumprx.gov Used for: TrumpRx: zepbound injection-vial 2.5 mg
  • Page did not load: "strength":"5","quantity":"1","price":{"trxPrice":39900,"beforePrice":108700} trumprx.gov Used for: TrumpRx: zepbound injection-vial 5 mg
  • Page did not load: "strength":"7.5","quantity":"1","price":{"trxPrice":44900,"beforePrice":108700} trumprx.gov Used for: TrumpRx: zepbound injection-vial 7.5 mg
  • Page did not load: "strength":"10","quantity":"1","price":{"trxPrice":44900,"beforePrice":108700} trumprx.gov Used for: TrumpRx: zepbound injection-vial 10 mg
  • Page did not load: "strength":"12.5","quantity":"1","price":{"trxPrice":44900,"beforePrice":108700} trumprx.gov Used for: TrumpRx: zepbound injection-vial 12.5 mg
  • Page did not load: "strength":"15","quantity":"1","price":{"trxPrice":44900,"beforePrice":108700} trumprx.gov Used for: TrumpRx: zepbound injection-vial 15 mg
  • Page did not load: "strength":"2.5","quantity":"1","price":{"trxPrice":29900,"beforePrice":49900} trumprx.gov Used for: TrumpRx: zepbound injection-pen 2.5 mg
  • Page did not load: "strength":"5","quantity":"1","price":{"trxPrice":39900,"beforePrice":49900} trumprx.gov Used for: TrumpRx: zepbound injection-pen 5 mg
  • Page did not load: "strength":"7.5","quantity":"1","price":{"trxPrice":44900,"beforePrice":49900} trumprx.gov Used for: TrumpRx: zepbound injection-pen 7.5 mg
  • Page did not load: "strength":"10","quantity":"1","price":{"trxPrice":44900,"beforePrice":69900} trumprx.gov Used for: TrumpRx: zepbound injection-pen 10 mg
  • Page did not load: "strength":"12.5","quantity":"1","price":{"trxPrice":44900,"beforePrice":69900} trumprx.gov Used for: TrumpRx: zepbound injection-pen 12.5 mg
  • Page did not load: "strength":"15","quantity":"1","price":{"trxPrice":44900,"beforePrice":69900} trumprx.gov Used for: TrumpRx: zepbound injection-pen 15 mg
  • Page did not load: "strength":"0.8","quantity":"30","price":{"trxPrice":14900,"beforePrice":64900} trumprx.gov Used for: TrumpRx: foundayo pill 0.8 mg
  • Page did not load: "strength":"2.5","quantity":"30","price":{"trxPrice":14900,"beforePrice":64900} trumprx.gov Used for: TrumpRx: foundayo pill 2.5 mg
  • Page did not load: "strength":"5.5","quantity":"30","price":{"trxPrice":19900,"beforePrice":64900} trumprx.gov Used for: TrumpRx: foundayo pill 5.5 mg
  • Page did not load: "strength":"9","quantity":"30","price":{"trxPrice":29900,"beforePrice":64900} trumprx.gov Used for: TrumpRx: foundayo pill 9 mg
  • Page did not load: "strength":"14.5","quantity":"30","price":{"trxPrice":29900,"beforePrice":64900} trumprx.gov Used for: TrumpRx: foundayo pill 14.5 mg
  • Page did not load: "strength":"17.2","quantity":"30","price":{"trxPrice":29900,"beforePrice":64900} trumprx.gov Used for: TrumpRx: foundayo pill 17.2 mg
  • Page did not load: "strength":"2.5/0.5","quantity":"1","price":{"trxPrice":49900,"beforePrice":111216} trumprx.gov Used for: TrumpRx: mounjaro injection-pen 2.5 mg
  • Page did not load: "strength":"5/0.5","quantity":"1","price":{"trxPrice":49900,"beforePrice":111216} trumprx.gov Used for: TrumpRx: mounjaro injection-pen 5 mg
  • Page did not load: "strength":"7.5/0.5","quantity":"1","price":{"trxPrice":49900,"beforePrice":111216} trumprx.gov Used for: TrumpRx: mounjaro injection-pen 7.5 mg
  • Page did not load: "strength":"10/0.5","quantity":"1","price":{"trxPrice":49900,"beforePrice":111216} trumprx.gov Used for: TrumpRx: mounjaro injection-pen 10 mg
  • Page did not load: "strength":"12.5/0.5","quantity":"1","price":{"trxPrice":49900,"beforePrice":111216} trumprx.gov Used for: TrumpRx: mounjaro injection-pen 12.5 mg
  • Page did not load: "strength":"15/0.5","quantity":"1","price":{"trxPrice":49900,"beforePrice":111216} trumprx.gov Used for: TrumpRx: mounjaro injection-pen 15 mg
  • Page did not load: New patients pay $199* for the first two monthly fills of Wegovy® (semaglutide) injection 0.25mg and 0.5mg, then $349/month. trumprx.gov Used for: TrumpRx: wegovy injection-pen 0.25 mg; TrumpRx: wegovy injection-pen 0.5 mg
  • Page did not load: For each fill after, pay $349/month for Wegovy® 0.25mg, 0.5mg, 1mg, 1.7mg, or 2.4mg and $399/month for Wegovy® HD 7.2mg. trumprx.gov Used for: TrumpRx: wegovy injection-pen 1 mg; TrumpRx: wegovy injection-pen 1.7 mg; TrumpRx: wegovy injection-pen 2.4 mg; TrumpRx: wegovy injection-pen 7.2 mg (HD); Article: trumprx-with-insurance-or-medicare; Article: wegovy-patient-assistance; Article: why-glp-1s-cost-more-in-the-us
  • Page did not load: "strength":"1.5","quantity":"30","price":{"trxPrice":14900,"beforePrice":134902} trumprx.gov Used for: TrumpRx: wegovy pill 1.5 mg
  • Page did not load: "strength":"4","quantity":"30","price":{"trxPrice":19900,"beforePrice":134902} trumprx.gov Used for: TrumpRx: wegovy pill 4 mg
  • Page did not load: "strength":"9","quantity":"30","price":{"trxPrice":29900,"beforePrice":134902} trumprx.gov Used for: TrumpRx: wegovy pill 9 mg
  • Page did not load: "strength":"25","quantity":"30","price":{"trxPrice":29900,"beforePrice":134902} trumprx.gov Used for: TrumpRx: wegovy pill 25 mg
  • Page did not load: New self-pay patients pay $199* for the first two monthly fills of Ozempic® (semaglutide) injection 0.25mg or 0.5mg. trumprx.gov Used for: TrumpRx: ozempic injection-pen 0.25 mg; TrumpRx: ozempic injection-pen 0.5 mg
  • Page did not load: For each fill after, pay $349/month for Ozempic® 0.25mg, 0.5mg or 1mg, and $499/month for Ozempic® 2mg. trumprx.gov Used for: TrumpRx: ozempic injection-pen 1 mg; TrumpRx: ozempic injection-pen 2 mg
  • Page did not load: "strength":"1.5","quantity":"30","price":{"trxPrice":14900,"beforePrice":102751} trumprx.gov Used for: TrumpRx: ozempic pill 1.5 mg
  • Page did not load: "strength":"4","quantity":"30","price":{"trxPrice":19900,"beforePrice":102751} trumprx.gov Used for: TrumpRx: ozempic pill 4 mg
  • Page did not load: "strength":"9","quantity":"30","price":{"trxPrice":29900,"beforePrice":102751} trumprx.gov Used for: TrumpRx: ozempic pill 9 mg
  • Page did not load: Once-weekly Zepbound is a prescription medicine that may help adults with obesity, or some adults with overweight who also have weight-related medical problems to lose excess body weight and keep it off. zepbound.lilly.com Used for: Guide: What the law and the makers say
  • Page did not load: Foundayo is a prescription medicine used with a reduced-calorie diet and increased physical activity to help adults with obesity, or some adults with overweight who also have weight-related medical problems, to lose excess body weight and keep the weight off. foundayo.lilly.com Used for: Guide: What the law and the makers say
  • Page did not load: Mounjaro is a prescription medicine available as a pre-filled single-dose pen in 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg per 0.5 mL injection. lilly.com Used for: Guide: What the law and the makers say
  • Page did not load: If you take a Lilly medicine and are currently unemployed, or if you have limited income and don't have insurance, you may qualify for free Lilly medicine through the Lilly Cares Foundation, a separate nonprofit organization that provides donated Lilly medications at no cost to qualifying patients. lilly.com Used for: Guide: Lilly Cares Foundation; Article: mounjaro-patient-assistance; Article: zepbound-patient-assistance
  • Page did not load: Visit lillycares.com for more information. lilly.com Used for: Guide: Lilly Cares Foundation; Article: mounjaro-patient-assistance; Article: zepbound-patient-assistance
  • Page did not load: It's now also approved to lower the risk of heart attack, stroke, or cardiovascular death for adults with type 2 diabetes at high risk for these events. mounjaro.lilly.com Used for: News: Mounjaro: a new indication
  • Page did not load: LillyDirect is Eli Lilly and Company's direct to patient pharmacy experience. lilly.com Used for: lillydirect: commitment; Review: lillydirect
  • Page did not load: To continue to be eligible for this Zepbound Self Pay Journey Program purchase offer you must complete your refill purchase of the Zepbound single-dose vial or KwikPen within 45 days of the delivery/received date of your previous Zepbound single-dose vial or KwikPen prescription. lilly.com Used for: lillydirect: commitment; Review: lillydirect
  • Page did not load: If refill purchase is completed more than 45 days after the delivery/receipt of your previous Zepbound single-dose vial or KwikPen prescription, purchase offer will not apply. lilly.com Used for: lillydirect: commitment
  • Page did not load: The cost for any prescribed medication is separate from the cost and coverage details shown here. lilly.com Used for: lillydirect: medicationIncluded
  • Page did not load: Please note the rates below, reported by providers, do not include medication costs; rates may vary. lilly.com Used for: lillydirect: medicationIncluded
  • Page did not load: Yes, you will need to purchase injection supplies for both the KwikPen and Vial. You can purchase supplies through LillyDirect checkout, at a local pharmacy, or online. lilly.com Used for: lillydirect: medicationIncluded
  • Page did not load: LillyDirect currently works with four dispensing pharmacies: Amazon Pharmacy, Fuze Health, Gifthealth, and Walmart Pharmacy. lilly.com Used for: lillydirect: medicationIncluded; Review: lillydirect
  • Page did not load: Zepbound requires a valid prescription from a licensed healthcare provider. lilly.com Used for: lillydirect: medicationIncluded; Review: lillydirect
  • Page did not load: KwikPen is available through LillyDirect self-pay with free home delivery or retail pickup at Walmart Pharmacy. lilly.com Used for: Retail: LillyDirect (Lilly)
  • Page did not load: Vial is available exclusively through LillyDirect self-pay. You can choose between free home delivery or free retail pickup at Walmart Pharmacy. lilly.com Used for: Retail: LillyDirect (Lilly)
  • Page did not load: Zepbound is available through LillyDirect and retail pharmacies for patients who are insured or plan to self-pay without using insurance. lilly.com Used for: Retail: LillyDirect (Lilly); Review: lillydirect
  • Page did not load: Walmart Pharmacy In-store pickup walmart.com/pharmacy 1-800-925-6278 lilly.com Used for: Retail: LillyDirect (Lilly)
  • Page did not load: Delivery now available: Zepbound®* KwikPen® & Single dose vials from Walmart Pharmacy Introducing a new way to get Zepbound® — direct‑to‑consumer pricing, delivery & in‑store pickup from your local Walmart Pharmacy. walmart.com Used for: Retail: Walmart
  • Page did not load: **subject to program terms and eligibility determined by LillyDirect. ***Subject to availability. Restrictions & fees may apply. walmart.com Used for: Retail: Walmart
  • Page did not load: Lilly's direct-to-consumer pricing and program requirements are established and owned by the manufacturer (Lilly); the pricing is not Walmart's usual and customary (U&C) prices and they are not prices available to the general public. walmart.com Used for: Retail: Walmart
  • Page did not load: Eligibility criteria are determined by LillyDirect. If you are an accepted participant in the program, you'll be guided through the process and invited to select your pickup location at Walmart Pharmacy. walmart.com Used for: Retail: Walmart
  • Page did not load: The direct-to-consumer pricing offered through this program is aligned with the cost structure established by LillyDirect. walmart.com Used for: Retail: Walmart
  • Page did not load: Mounjaro is available for self-pay through LillyDirect. Start by talking to your doctor to see if Mounjaro is right for you, then follow the steps below. lilly.com Used for: Retail: LillyDirect (Lilly)
  • Page did not load: We deliver authentic Lilly medicines to your home, if prescribed. We can also provide support if you choose pickup at a retail pharmacy near you. lilly.com Used for: Retail: LillyDirect (Lilly)
  • Not found: Some drugs may also have quantity (amount) limits and some drugs are never covered, such as drugs for weight loss. molinahealthcare.com Used for: Insurer molina: weightLossCovered
  • Not found: *Drugs used for anorexia, weight loss, or weight gain are excluded from coverage. molinamarketplace.com Used for: Insurer molina: weightLossCovered
  • Not found: Weight Loss Management SA Form -- updated September 2024 molinahealthcare.com Used for: Insurer molina: paCriteria
  • Not found: Wegovy (semaglutide) NC C27682-A molinahealthcare.com Used for: Insurer molina: paCriteria
  • Not found: Zepbound (tirzepatide) NC C29112-A molinahealthcare.com Used for: Insurer molina: paCriteria
  • Not found: GLP-1 RAs for Cardiovascular Risk Reduction SA Form -- September 2024 molinahealthcare.com Used for: Insurer molina: cv
  • Not found: Beginning July 1, 2024, the mediations below will have a change to prior authorization criteria. molinamarketplace.com Used for: Insurer molina: t2d
  • Not found: Byetta CC, QL, Ozempic AE, CC, QL, Trulicity CC, QL, Victoza CC, QL. molinamarketplace.com Used for: Insurer molina: t2d
  • Not found: • Diagnosis of Type II Diabetes Mellitus (T2DM) confirmed with clinical documentation (e.g., progress note) of one of the following: o ICD-10 diagnosis of T2DM; OR molinamarketplace.com Used for: Insurer molina: t2d
  • Not found: Approval Duration: 6 months molinamarketplace.com Used for: Insurer molina: t2d
  • Not found: Use our preferred drug list search tool to: molinahealthcare.com Used for: Insurer molina: howToCheck
  • Not found: See if your medicine has quantity limits, has age limits, or requires Prior Authorization. molinahealthcare.com Used for: Insurer molina: howToCheck
  • Not found: You can contact our Pharmacy team at (800) 665-3086, TTY 711, 7 days a week, molinahealthcare.com Used for: Insurer molina: howToCheck
  • Not found: Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Glucose-dependent Insulinotropic Polypeptide (GIP) Receptor Agonist DOC FFS 04-29-2025 ilpriorauth.com Used for: Medicaid IL: t2d
  • Page did not load: See https://www.mainecarepdl.org for a list of medications your doctor can prescribe. maine.gov Used for: Medicaid ME: agency
  • Page did not load: †For 7.5 mg, 10 mg, 12.5 mg and 15 mg doses, prices reflect monthly cost with Zepbound Journey Program. Regular prices will apply if prescription is not refilled within 45 days ($499 for 7.5mg, $699 for 10mg, $699 for 12.5mg, and $699 for 15mg). lilly.com Used for: Article: compounded-vs-brand-glp-1-price; Article: glp-1-statistics
  • Page did not load: You will automatically receive the $449 purchase offer on your first purchase of the 7.5 mg, 10 mg, 12.5 mg, or 15 mg Zepbound single-dose vial or KwikPen beginning February 23, 2026. lilly.com Used for: Article: glp-1-price-changes-2026
  • Page did not load: Prices for the 2.5 mg and 5.5 mg dose are temporarily reduced through December 31, 2026. lilly.com Used for: Article: glp-1-price-changes-2026
  • Page did not load: 15 mg/0.6 mL Self-pay price: Starting at $449/month* when you refill within 45 days lilly.com Used for: Article: glp-1-price-changes-2026; Article: insurance-dropped-glp-1-coverage; Article: trumprx-with-insurance-or-medicare; Article: wegovy-vs-zepbound-5-year-cost
  • Page did not load: 0.8 mg dose (starting dosage) Self-pay price: Starting at $149/month lilly.com Used for: Article: glp-1-price-changes-2026; Article: hims-hers-glp-1-cost; Review: hims-hers
  • Page did not load: 15 mg/0.5 mL Self-pay price: Starting at $449/month* when you refill within 45 days lilly.com Used for: Article: hims-hers-glp-1-cost
  • Page did not load: Self-pay price: Starting at $299/month lilly.com Used for: Article: is-push-health-legit
  • Page did not load: If I am enrolled in Medicare Part D, I will not count any portion of the amount I pay for Mounjaro under the Program, or any costs associated with my purchase of Mounjaro under the Program, towards my Medicare Part D true out-of-pocket ("TrOOP") costs. lilly.com Used for: Article: mounjaro-patient-assistance
  • Page did not load: For 7.5 mg, 10 mg, 12.5 mg and 15 mg doses, prices reflect monthly cost with Zepbound Journey Program. Regular prices will apply if prescription is not refilled within 45 days ($499 for 7.5mg, $699 for 10mg, $699 for 12.5mg, and $699 for 15mg). lilly.com Used for: Article: restarting-glp-1-after-a-break
  • Page did not load: Zepbound requires a valid prescription from a licensed healthcare provider. Ask your doctor to send your prescription to LillyDirect Pharmacy: lilly.com Used for: Article: switch-glp-1-programs
  • Page did not load: If you are switching from another medication, it’s important to talk to your healthcare provider about the right approach for you. lilly.com Used for: Article: switch-glp-1-programs
  • Page did not load: Regular prices will apply if prescription is not refilled within 45 days ($499 for 7.5mg, $699 for 10mg, $699 for 12.5mg, and $699 for 15mg). lilly.com Used for: Article: switch-glp-1-programs; Article: wegovy-vs-zepbound-5-year-cost; Article: zepbound-patient-assistance; Review: lillydirect; Review: weightwatchers-med
  • Page did not load: Requirements vary by insurer, and the process can take anywhere from a few days to a few weeks to complete lilly.com Used for: Article: switch-glp-1-programs
  • Page did not load: This is an out-of-pocket price. If you have insurance, check your co-pay first trumprx.gov Used for: Article: trumprx-with-insurance-or-medicare
  • Page did not load: you must (1) not ask your insurance to pay you back for the money that you self-paid for your medication using this offer; (2) cannot attempt to count the cost of this medicine toward your insurance deductible or out-of-pocket limit trumprx.gov Used for: Article: trumprx-with-insurance-or-medicare
  • Page did not load: examples include but are not limited to Medicare, Medicare Part D, a Medicare Advantage Prescription Plan, insurance through US Veterans Affairs (VA), US Department of Defense (DOD), TRICARE, Medicaid trumprx.gov Used for: Article: trumprx-with-insurance-or-medicare
  • Page did not load: you must tell your insurance company that you bought this medicine outside of its prescription plan using the Wegovy® self-pay offer and that you are not seeking reimbursement or submitting a claim for this prescription trumprx.gov Used for: Article: trumprx-with-insurance-or-medicare
  • Page did not load: Eligibility and restrictions apply. Government beneficiaries excluded. trumprx.gov Used for: Article: trumprx-with-insurance-or-medicare
  • Page did not load: You agree that the Card is for self-paying (cash) patients only and that you will not seek or accept reimbursement for any out-of-pocket costs for Zepbound® single-patient-use KwikPen purchased with the Card from any third-party payer, including private insurance or state or federal healthcare programs lilly.com Used for: Article: trumprx-with-insurance-or-medicare; Article: zepbound-patient-assistance
  • Page did not load: 1-month supply is defined as 28 days and 4 single-dose vials or 1 KwikPen. lilly.com Used for: Article: wegovy-vs-zepbound-5-year-cost; Article: zepbound-patient-assistance
  • Page did not load: This purchase offer may be terminated, rescinded, revoked, or amended by Lilly at any time, with or without notice, for any reason. lilly.com Used for: Article: wegovy-vs-zepbound-5-year-cost; Article: zepbound-patient-assistance
  • Page did not load: Terms and conditions apply. Pen needle purchase required. lilly.com Used for: Article: wegovy-vs-zepbound-5-year-cost
  • Page did not load: KwikPen is a multi-dose pen that holds four doses of Zepbound medicine, one for each week of the month. lilly.com Used for: Article: what-is-tirzepatide
  • Page did not load: Original Price $1,349.02 trumprx.gov Used for: Article: why-glp-1s-cost-more-in-the-us
  • Page did not load: Original Price $1,027.51 trumprx.gov Used for: Article: why-glp-1s-cost-more-in-the-us
  • Page did not load: Limited Time Offer – New patients pay $199* for the first two monthly fills of Wegovy® (semaglutide) injection 0.25mg and 0.5mg, then $349/month. trumprx.gov Used for: Article: why-glp-1s-cost-more-in-the-us
  • Page did not load: 10 mg/0.6 mL Self-pay price: Starting at $449/month* when you refill within 45 days lilly.com Used for: Article: zepbound-patient-assistance
  • Not found: Compounded Semaglutide Weight Loss GLP-1 Weekly injection $119/mo Compounded joinbelle.com Used for: Review: belle
  • Not found: Compounded Tirzepatide Weight Loss Dual GLP-1/GIP Weekly injection $199/mo Compounded joinbelle.com Used for: Review: belle
  • Not found: Dual-Action GLP-1 + GIP Compounded Tirzepatide from $ 189 / month joinbelle.com Used for: Review: belle
  • Not found: You can cancel anytime directly through your account. Once a prescription has been sent to the pharmacy, however, that specific order can't be cancelled, returned, or refunded, as federal regulations prohibit returns on prescription and compounded medications. help.joinbelle.com Used for: Review: belle
  • Page did not load: $39/mo. to start your weight loss treatment goodrx.com Used for: Review: goodrx-weight-loss
  • Page did not load: Medication cost not included. GoodRx is NOT insurance. Cancel anytime. goodrx.com Used for: Review: goodrx-weight-loss
  • Page did not load: Only FDA-approved medications goodrx.com Used for: Review: goodrx-weight-loss
  • Page did not load: Wegovy pen offer applies only to first two fills at 0.25 or 0.5 mg doses and ends 12/31/26—price increases to $349 after the first two fills. goodrx.com Used for: Review: goodrx-weight-loss
  • Page did not load: Wegovy HD offer applies only to 7.2 mg dose and ends 12/31/26, priced at $399 for 1 carton, $798 for 2 cartons, or $1197 for 3 cartons per month. goodrx.com Used for: Review: goodrx-weight-loss
  • Page did not load: Wegovy tablet offer applies only to 1.5 mg. 4 mg dose is $199/month. Higher doses start at $299/month. goodrx.com Used for: Review: goodrx-weight-loss
  • Page did not load: Foundayo™ offer applies only to 0.8 mg and 2.5 mg dose until 12/31/26. 5.5 mg dose is $199 until 12/31/26 (higher doses are $299/month). goodrx.com Used for: Review: goodrx-weight-loss
  • Page did not load: You can also access Zepbound (tirzepatide) KwikPens through GoodRx starting at $299 per month. goodrx.com Used for: Review: goodrx-weight-loss
  • Page did not load: As low as $ 149 per month 1 Available Wegovy® Pill goodrx.com Used for: Review: goodrx-weight-loss
  • Page did not load: Weight loss treatment via GoodRx Care Direct is not available in Alabama or Louisiana at this time. goodrx.com Used for: Review: goodrx-weight-loss
  • Page did not load: You can cancel anytime by visiting the treatment plan page from your account dashboard and selecting "Cancel" at least one day before your subscription plan renews to avoid future charges. goodrx.com Used for: Review: goodrx-weight-loss
  • Page did not load: Currently, GoodRx Care Direct offers Subscription Cycle options ranging from one, three, six and twelve month renewals. goodrx.com Used for: Review: goodrx-weight-loss
  • Page did not load: Amounts paid for telehealth visits and prescriptions are not refundable. goodrx.com Used for: Review: goodrx-weight-loss
  • Page did not load: GoodRx Care Direct cannot be combined with federal or state-funded programs such as Medicare or Medicaid. goodrx.com Used for: Review: goodrx-weight-loss
  • Page did not load: These Services include prescription fulfillment services made available through licensed pharmacies, including Birdi, Inc., HealthDyne, LLC, Truepill Inc. dba FuzeRx, and HoneyBee Health, Inc. (collectively, the “Pharmacies”). goodrx.com Used for: Review: goodrx-weight-loss
  • Page did not load: Alternatively, you can use a GoodRx coupon at your pharmacy to get Wegovy or Zepbound pens at a discount. goodrx.com Used for: Review: goodrx-weight-loss
  • Page did not load: LillyDirect works with licensed third-party dispensing pharmacies to fill your prescription and deliver your medicine. lilly.com Used for: Review: lillydirect
  • Page did not load: Ask your doctor to send your prescription to LillyDirect Pharmacy. If you need a doctor, we'll help you connect with care. lilly.com Used for: Review: lillydirect
  • Page did not load: Providers apply their independent clinical judgment to decide if medication is right for you. Lilly does not endorse or recommend these health care providers. Please note the rates below, reported by providers, do not include medication costs; rates may vary. lilly.com Used for: Review: lillydirect
  • Page did not load: Yes, you will need to purchase injection supplies for both the KwikPen and Vial. lilly.com Used for: Review: lillydirect
  • Page did not load: Exclusively available through LillyDirect | Self-pay only | Free delivery | Pickup available lilly.com Used for: Review: lillydirect
  • Page did not load: Insurance price: Pay as low as $25* per month for up to a 3-month prescription lilly.com Used for: Review: lillydirect
  • Page did not load: Governmental beneficiaries excluded. Eligibility required, terms and conditions apply. Savings subject to monthly and annual limits. Month is defined as 28-days and up to 4 single-dose pens. lilly.com Used for: Review: lillydirect
  • Page did not load: We automatically check your insurance coverage routinely and support you if prior authorization is required. lilly.com Used for: Review: lillydirect
  • Page did not load: *Prices for the 2.5 mg and 5.5 mg dose are temporarily reduced through December 31, 2026. lilly.com Used for: Review: lillydirect
  • Page did not load: For 14.5 mg and 17.2 mg doses, prices reflect monthly cost with Foundayo Self-Pay Journey Program. Regular prices will apply if prescription is not refilled within 45 days. lilly.com Used for: Review: lillydirect
  • Page did not load: Self-pay only . Prescription required. Additional taxes and fees may apply. Month is defined as 30-days. lilly.com Used for: Review: lillydirect
  • Page did not load: HSA/FSA eligible: Eligibility may vary by plan lilly.com Used for: Review: lillydirect
  • Not found: $39 promotional rate available for new subscribers only. After the first month, monthly membership fee increases to $79/month. Promotional pricing not available in all states. joinmochi.com Used for: Review: mochi-health
  • Page did not load: GLP-1 medications as low as $25 with insurance, $149 without. Plus members get free delivery! See SamsClub.com/GLP1 for more. samsclub.com Used for: Review: sams-club-health
  • Page did not load: Zepbound KwikPen now available, starting at $299 self-pay for a starter dose with manufacturer offer. Free delivery for Plus. samsclub.com Used for: Review: sams-club-health
  • Page did not load: Eligible Medicare patients may qualify for weight loss GLP-1s for $50/month. Medicare GLP-1 Bridge available now. samsclub.com Used for: Review: sams-club-health
  • Page did not load: Availability varies by location and supply chain conditions. Please contact your local Sam's Club Pharmacy to inquire about specific prescriptions. samsclub.com Used for: Review: sams-club-health
  • Page did not load: *Sam’s Club Members who do not have an active WW Med+ subscription pay $149 for a 3-month WW Med+ plan. The full cost of $149 is due at purchase. Plan auto-renews for another 3-month period at $149 paid upfront at the end of each plan term unless canceled. samsclub.com Used for: Review: sams-club-health
  • Page did not load: Programs do not include the cost of GLP-1 medications. Medications require eligibility and a prescription. All medical services are provided through our affiliated medical group, WeightWatchers Clinic. samsclub.com Used for: Review: sams-club-health
  • Page did not load: Curai offers virtual urgent care, primary care, chronic care, lab orders, prescription, and weight management services. samsclub.com Used for: Review: sams-club-health
  • Page did not load: *Promotional free visits are not available to individuals enrolled in Medicare or Medicaid. Sam's Club works with third parties to connect members with providers. The third party listing is sponsored. samsclub.com Used for: Review: sams-club-health
  • Page did not load: 24/7 virtual care, $0 per visit Weight management & more. Offer valid through Aug. 31. samsclub.com Used for: Review: sams-club-health
  • Page did not load: Anywhere in the U.S., subject to provider availability and state licensing. samsclub.com Used for: Review: sams-club-health
  • Page did not load: No. Medical care is provided by Curai’s health care providers. samsclub.com Used for: Review: sams-club-health
  • Page did not load: Insurance coverage varies by plan. Eligible services or prescriptions may qualify for HSA/FSA reimbursement. samsclub.com Used for: Review: sams-club-health
  • Page did not load: 2.5 mg/0.6 mL (starting dosage) Self-pay price: Starting at $299/month lilly.com Used for: Review: shed
  • Not found: 6 months 6-month commitment $120 /month $720 billed every 6 months $175 /month $1,050 billed every 6 months trytrimi.com Used for: Review: trimi

A sentence that is not found keeps its old date; after 7 days the price is marked as not re-checked until a person reads the page again. Fixes are logged on the corrections page.

In files we did not re-read

Every page we opened

Official pageSentences still there
foundayo.lilly.com/0 of 2
goodrx.com/care/services/glp-1-weight-loss0 of 11
goodrx.com/classes/glp-1-agonists/glp-1-drugs-cost-and-savings0 of 1
goodrx.com/go/ed-care-terms0 of 4
help.joinbelle.com/en/articles/16648651-cancelling-your-subscription1 of 2
ilpriorauth.com/pages/140 of 1
joinbelle.com/1 of 2
joinbelle.com/treatments4 of 6
joinmochi.com/9 of 10
lilly.com/about/contact0 of 3
lilly.com/lillydirect0 of 4
lilly.com/lillydirect/foundayo0 of 12
lilly.com/lillydirect/foundayo/foundayo-full-terms-conditions0 of 11
lilly.com/lillydirect/mounjaro0 of 8
lilly.com/lillydirect/mounjaro/mounjaro-purchase-terms0 of 1
lilly.com/lillydirect/rx-support0 of 2
lilly.com/lillydirect/zepbound0 of 42
lilly.com/lillydirect/zepbound/zepbound-tirzepatide-full-terms-conditions0 of 21
lilly.com/news/media/mounjaro0 of 1
maine.gov/dhhs/oms/mainecare-options/covered-services-benefits0 of 1
molinahealthcare.com/marketplace/nv/en-us/Providers/Drug-List0 of 2
molinahealthcare.com/members/tx/en-US/mem/medicare/drug/drug0 of 1
molinahealthcare.com/providers/il/medicaid/drug/formulary.aspx0 of 3
molinahealthcare.com/providers/va/medicaid/resources/forms.aspx0 of 2
molinamarketplace.com/providers/ky/medicaid/comm/newsarticlepage.aspx?ArticleID=259%20eNews%20GLP1%20Criteria%20Change&lob=&type=IsNewsMediaSpecial&year=All&State=ALL&ArticlePageLink=/providers/ky/medicaid/comm/newsarticlepage.aspx0 of 5
mounjaro.lilly.com/0 of 2
mounjaro.lilly.com/savings-coverage0 of 12
mounjaro.lilly.com/what-is-mounjaro0 of 1
samsclub.com/cp/curai-health-telehealth/158001420 of 6
samsclub.com/cp/glp-1-support/138201610 of 6
trumprx.gov/p/foundayo0 of 6
trumprx.gov/p/mounjaro0 of 6
trumprx.gov/p/ozempic0 of 3
trumprx.gov/p/ozempic-pill0 of 3
trumprx.gov/p/wegovy0 of 10
trumprx.gov/p/wegovy-pill0 of 5
trumprx.gov/p/zepbound0 of 7
trumprx.gov/p/zepbound-kwikpen0 of 7
trytrimi.com/blog/trimi-pricing-subscription-shipping2 of 3
walmart.com/cp/lillydirect/58872250 of 5
zepbound.lilly.com/0 of 1
aad.org/public/everyday-care/skin-care-secrets/prevent-skin-problems/glp1-drugs-and-side-effects3 of 3
aafprs.org/Media/Press_Releases/The_Ozempic_Face.aspx2 of 2
aarpmedicareplans.com/shop/prescription-drug-plans.html1 of 1
aboutamazon.com/news/retail/amazon-glp1-management-program12 of 12
aboutamazon.com/news/retail/amazon-pharmacy-glp-1-medicare2 of 2
accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=0217732 of 2
accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=0223411 of 1
accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=2063211 of 1
accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=2096372 of 2
accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=2130511 of 1
accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=2152563 of 3
accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=2158663 of 3
accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=2178063 of 3
accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=2183162 of 2
accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=2203142 of 2
accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=2209342 of 2
accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=001&Appl_No=209637&Appl_type=N5 of 5
accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=001&Appl_No=215256&Appl_type=N3 of 3
accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=001&Appl_No=218316&Appl_type=N1 of 1
accessdata.fda.gov/scripts/cder/ob/results_exclusivity.cfm1 of 1
accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Liraglutide%20Injection&st=d1 of 1
admincode.legislature.state.al.us/api/graphql?operationName=publicCode&variables=%7B%22number%22%3A%22560-X-16-.01%22%7D&extensions=%7B%22persistedQuery%22%3A%7B%22version%22%3A1%2C%22sha256Hash%22%3A%22a7128a1df313f43c76196950e7339e8d12d27420%22%7D%7D2 of 2
aetna.com/cpb/medical/data/1_99/0039.html1 of 1
aetna.com/employers-organizations/glp1-benefits-coverage.html1 of 1
aetna.com/faqs-health-insurance/pharmacy-faqs.html4 of 4
aetna.com/medicare/understanding-medicare/does-medicare-cover-ozempic.html2 of 2
aetna.com/medicare/understanding-medicare/medicare-glp-1-weight-loss-drug-coverage.html5 of 5
aetna.com/products/rxnonmedicare/data/2026/Antidiabetic_GLP-1,_GIP-GLP-1_Agonist_PA_with_Limit_2439-C_P05-2025_v4.html2 of 2
aetna.com/products/rxnonmedicare/data/2026/Weight_Loss_(BMI%2035)_GIP-GLP-1,_GLP-1_Agonists_PA_with_Limit_6450-C_P08-2025_v8.html18 of 18
ahca.myflorida.com/medicaid/medicaid-policy-quality-and-operations/medicaid-policy-and-quality/medicaid-policy/pharmacy-policy/prescribed-drug-services.html1 of 1
ahca.myflorida.com/medicaid/prescribed-drugs/drug-criteria.html1 of 1
akleg.gov/basis/aac.asp?media=print&secStart=7.120.112&secEnd=7.120.1121 of 1
ambetterhealth.com/en/ar/provider-resources/provider-news/glucagon-like-peptide-1-agonists-for-weight-loss/1 of 1
ambetterhealth.com/en/ar/resources/member-news/glp-1-medications-coverage-exclusions-for-weight-loss-treatment/2 of 2
ambetterhealth.com/en/tx/provider-resources/provider-news/effective-march-first-2026-pharmacy-and-biopharmacy-policy-updates/6 of 6
ambetterhealth.com/en/tx/provider-resources/provider-news/pharmacy-and-biopharmacy-policies-effective-june-2026/4 of 4
ambetterhealth.com/en/tx/resources/pharmacy-resources/3 of 3
amgen.com/newsroom/press-releases/2025/06/results-from-amgens-phase-2-obesity-study-of-monthly-maritide-presented-at-the-american-diabetes-association-85th-scientific-sessions2 of 2
amgen.com/newsroom/press-releases/2026/08/amgen-reports-second-quarter-2026-financial-results2 of 2
anthem.com/ca/ms/pharmacyinformation/priorauth.html2 of 2
anthem.com/pharmacy-information/drug-list-formulary1 of 1
anthem.com/pharmacy-information/for-members1 of 1
app.leg.wa.gov/wac/default.aspx?cite=182-530-21003 of 3
apps.legislature.ky.gov/law/kar/titles/907/023/010/3 of 3
apps.legislature.ky.gov/law/kar/titles/907/023/010/16437/2 of 2
apps.legislature.ky.gov/law/kar/titles/907/023/010/REG/1 of 1
apps.legislature.ky.gov/law/statutes/chapter.aspx?id=370841 of 1
apps.legislature.ky.gov/record/26rs/hb2.html2 of 2
apps.legislature.ky.gov/record/26rs/sb65.html2 of 2
arkleg.state.ar.us/Bills/Detail?id=HB1332&ddBienniumSession=2025%2F2025R1 of 1
arkleg.state.ar.us/Bills/Detail?id=HB1424&ddBienniumSession=2025%2F2025R2 of 2
aspe.hhs.gov/reports/comparing-prescription-drugs2 of 2
aspe.hhs.gov/topics/poverty-economic-mobility/poverty-guidelines1 of 1
azahcccs.gov/1 of 1
azleg.gov/legtext/57leg/2R/summary/S.1621HHS.DOCX.htm2 of 2
bcbsil.com/help-center2 of 2
bcbsil.com/prescription-drugs/managing-prescriptions/drug-lists1 of 1
bcbsil.com/producer/news/05-20-26-new-glp1-coverage-20269 of 9
bcbsil.com/provider/education/education-reference/news/2024/08-12-2024-30-day-supply-limit2 of 2
bcbsil.com/provider/education/education-reference/news/2025/5-20-2025-new-home-delivery-pharmacy-service-to-fill4 of 4
blueshieldca.com/en/bsp/medi-cal-members/pharmacy/medi-cal-rx-benefits1 of 1
blueshieldca.com/en/home/resources/pharmacy/drug-prior-authorizations1 of 1
blueshieldca.com/en/medicare/pharmacy-resources/medicare-formularies2 of 2
blueshieldca.com/en/provider/authorizations/policy-pharmacy/pharmacy-benefits1 of 1
blueshieldca.com/en/provider/news-education/news12 of 12
bms.wv.gov/prior-authorization-criteria2 of 2
boehringer-ingelheim.com/us/human-health/metabolic-diseases/results-phase-iii-synchronize-1-obesity-trial3 of 3
business.optum.com/en/pharmacy-benefit-management/affordability/weight-management.html2 of 2
capitol.texas.gov/BillLookup/History.aspx?LegSess=89R&Bill=HB26772 of 2
capitol.texas.gov/tlodocs/89R/fiscalnotes/html/HB02677H.htm1 of 1
carefirst.com/fedhmo/faqs/faqs-noom-med.html4 of 4
carefirst.com/fedhmo/plan-information/noom-med-enhanced-weight-management-support.html3 of 3
carefirst.com/medicare-options/compare-medicare-plans/pharmacy-faqs.html1 of 1
carelonrx.com/perspectives/glp1s-and-weight-loss-1012 of 2
carelonrx.com/perspectives/weight-management-program-updates3 of 3
cga.ct.gov/2026/sup/chap_319v.htm5 of 5
cga.ct.gov/current/pub/chap_319v.htm1 of 1
chfs.ky.gov/agencies/dms/dpo/ppb/Pages/default.aspx1 of 1
cigna.com/individuals-families/member-guide/offered-by-employers-drug-list1 of 1
cigna.com/individuals-families/member-guide/prescription-drug-lists2 of 2
clinicaltrials.gov/api/oas/v24 of 4
clinicaltrials.gov/api/v2/studies/NCT055677961 of 1
clinicaltrials.gov/api/v2/studies/NCT059290661 of 1
clinicaltrials.gov/api/v2/studies/NCT060665153 of 3
clinicaltrials.gov/api/v2/studies/NCT068588391 of 1
clinicaltrials.gov/api/v2/studies/NCT076684141 of 1
cloud.info.blueshieldca.com/xlob_bkr_news_December20247 of 7
cms.gov/marketplace/resources/data/essential-health-benefits2 of 2
cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge5 of 5
cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge/information-part-d-plans4 of 4
cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge/information-pharmacies4 of 4
cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge/information-providers18 of 18
cms.gov/newsroom/fact-sheets/contract-year-2026-policy-and-technical-changes-medicare-advantage-program-medicare-prescription1 of 1
cms.gov/newsroom/fact-sheets/contract-year-2026-policy-and-technical-changes-medicare-advantage-program-medicare-prescription-final1 of 1
cms.gov/newsroom/press-releases/cms-launches-medicare-glp-1-bridge-expanding-access-glp-1-medications3 of 3
cms.gov/newsroom/press-releases/coming-soon-cms-provide-50-monthly-access-glp-1-medications-medicare-beneficiaries2 of 2
cms.gov/newsroom/press-releases/hhs-announces-15-additional-drugs-selected-medicare-drug-price-negotiations-continued-effort-lower3 of 3
cms.gov/priorities/innovation/innovation-models/balance5 of 5
cobi-ws.utah.gov/api/tab/issues/detail/2025/1/23793.json1 of 1
cobi-ws.utah.gov/api/tab/issues/detail/2026/1/25486.json2 of 2
cobyhealth.com/6 of 6
cobyhealth.com/help4 of 4
cobyhealth.com/treatments/weight-loss/semaglutide2 of 2
cobyhealth.com/treatments/weight-loss/tirzepatide2 of 2
codes.ohio.gov/ohio-administrative-code/rule-5160-9-032 of 2
connect.bcbsil.com/health-and-wellness/b/weblog/posts/weight-loss-options2 of 2
consumer.ftc.gov/articles/truth-behind-weight-loss-ads6 of 6
content.govdelivery.com/accounts/MODSS/bulletins/3f4823a6 of 6
contenthub-aem.optumrx.com//graphql/execute.json/retail-pharmacy-override/getsdpdlcontent3 of 3
corporate.walmart.com/about/samsclub/news/2026/01/07/as-new-year-wellness-goals-take-shape-sams-club-helps-members-navigate-the-first-and-only-oral-glp-1-option3 of 3
costco.com/member-prescription-program.html1 of 1
ctdssmap.com/CTPortal/Pharmacy-Information4 of 4
cvs.com/content/weight-loss4 of 4
cvs.com/minuteclinic/services/weight-loss-program9 of 9
cvs.com/minuteclinic/virtual-care1 of 1
cvshealth.com/news/company-news/cvs-health-enhances-its-direct-to-consumer-weight-management-offerings.html2 of 2
dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=27f15fac-7d98-4114-a2ec-92494a91da9839 of 39
dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b92 of 92
dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c6262 of 62
dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d7947 of 47
dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc046 of 46
dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b163 of 163
data.capitol.hawaii.gov/session/measure_indiv.aspx?billtype=HB&billnumber=2456&year=20261 of 1
data.capitol.hawaii.gov/sessions/session2026/bills/HB2456_HD1_.HTM3 of 3
dc-pbm.com/provider-forms3 of 3
dhcf.dc.gov/service/right-rx-initiative1 of 1
dhhs.ne.gov/Pages/Medicaid-Provider-Pharmacy-Services.aspx1 of 1
dhhs.ne.gov/Pages/Medicaid-Services.aspx1 of 1
dhss.delaware.gov/dmma/1 of 1
docs.startwillow.com/en/articles/8838990-is-willow-covered-by-insurance2 of 2
dss.mo.gov/mhd/bulletins/morx-policy-regarding-cms-glp-1-bridge-demonstration-program-copayments1 of 1
dss.mo.gov/mhd/hot-tips/biopsychosocial-treatment-obesity1 of 1
dss.mo.gov/mhd/pharmacy2 of 2
dss.mo.gov/mhd/pharmacy-clinical-edits-pdl?pce=GLP2 of 2
dss.sd.gov/medicaid/providers/pa/1 of 1
dvha.vermont.gov/forms-manuals/forms/pharmacy-prior-authorization-request-forms-and-order-forms3 of 3
effecty.com/4 of 4
effecty.com/faq4 of 4
effecty.com/weight-loss/compounded-semaglutide3 of 3
effecty.com/weight-loss/compounded-tirzepatide2 of 2
effecty.com/weight-loss/wegovy2 of 2
effecty.com/weight-loss/zepbound2 of 2
ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-8-11-april-20242 of 2
enhance.md/faq8 of 8
enhance.md/product/advanced-tirzepatide1 of 1
enhance.md/product/core-semaglutide4 of 4
enhance.md/product/elite-tirzepatide-and-semaglutide1 of 1
enhance.md/shipping-returns1 of 1
eohhs.ri.gov/providers-partners/provider-directories/pharmacy2 of 2
ersnet.org/news-and-features/news/weight-loss-injection-semaglutide-can-reduce-asthma-attacks-by-up-to-40-per-cent/7 of 7
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=27633186&rettype=abstract&retmode=text1 of 1
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=28110911&rettype=abstract&retmode=text1 of 1
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=32379652&rettype=abstract&retmode=text1 of 1
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=33567185&rettype=abstract&retmode=text1 of 1
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=33755728&rettype=abstract&retmode=text2 of 2
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=34170647&rettype=abstract&retmode=text5 of 5
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=34186022&rettype=abstract&retmode=text1 of 1
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=35441470&rettype=abstract&retmode=text2 of 2
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=35658024&rettype=abstract&retmode=text2 of 2
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=36066977&rettype=abstract&retmode=text2 of 2
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=36216945&rettype=abstract&retmode=text1 of 1
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=36322838&rettype=abstract&retmode=text1 of 1
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=37541662&rettype=abstract&retmode=text3 of 3
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=37952131&rettype=abstract&retmode=text1 of 1
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=38017205&rettype=abstract&retmode=text3 of 3
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=38078870&rettype=abstract&retmode=text5 of 5
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=38206146&rettype=abstract&retmode=text1 of 1
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=38536176&rettype=abstract&retmode=text1 of 1
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=38740993&rettype=abstract&retmode=text1 of 1
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=38778151&rettype=abstract&retmode=text3 of 3
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=38785209&rettype=abstract&retmode=text1 of 1
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=38856224&rettype=abstract&retmode=text5 of 5
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=38874170&rettype=abstract&retmode=text1 of 1
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=38912654&rettype=abstract&retmode=text1 of 1
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=39536238&rettype=abstract&retmode=text2 of 2
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=39555826&rettype=abstract&retmode=text6 of 6
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=39556360&rettype=abstract&retmode=text7 of 7
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=39937469&rettype=abstract&retmode=text5 of 5
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=39996356&rettype=abstract&retmode=text2 of 2
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=40305708&rettype=abstract&retmode=text3 of 3
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=40353578&rettype=abstract&retmode=text6 of 6
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=40407186&rettype=abstract&retmode=text2 of 2
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=40450457&rettype=abstract&retmode=text4 of 4
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=40626110&rettype=abstract&retmode=text2 of 2
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=40934115&rettype=abstract&retmode=text1 of 1
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=40960239&rettype=abstract&retmode=text1 of 1
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=40961952&rettype=abstract&retmode=text1 of 1
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=41022371&rettype=abstract&retmode=text2 of 2
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=41291666&rettype=abstract&retmode=text2 of 2
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=41310257&rettype=abstract&retmode=text1 of 1
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=41406444&rettype=abstract&retmode=text1 of 1
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=41701618&rettype=abstract&retmode=text2 of 2
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=41998799&rettype=abstract&retmode=text2 of 2
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=42005929&rettype=abstract&retmode=text3 of 3
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=42517362&rettype=abstract&retmode=text2 of 2
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=42647098&rettype=abstract&retmode=text1 of 1
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=42730869&rettype=abstract&retmode=text3 of 3
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=42764399&rettype=abstract&retmode=text2 of 2
events.in.gov/event/governor-braun-announces-state-medicaid-program-will-now-cover-glp-1-treatments-for-eligible-beneficiaries3 of 3
evernorth.com/articles/evernorth-launches-new-benefit-option-drives-lower-net-cost-weight-loss-medicines1 of 1
evernorth.com/encirclerx-provider4 of 4
express-scripts.com/enguidepharmacy/help/frequently-asked-questions1 of 1
express-scripts.com/frequently-asked-questions/are-glp-1s-or-semaglutide-covered-my-plan2 of 2
fda.gov/consumers/consumer-updates/fda-101-dietary-supplements6 of 6
fda.gov/consumers/consumer-updates/it-really-fda-approved1 of 1
fda.gov/drugs/development-approval-process-drugs/frequently-asked-questions-patents-and-exclusivity2 of 2
fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize15 of 15
fda.gov/drugs/drug-alerts-and-statements/fda-warns-consumers-not-use-counterfeit-ozempic-semaglutide-found-us-drug-supply-chain5 of 5
fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss26 of 26
fda.gov/drugs/drug-approvals-and-databases/drugsfda-glossary-terms1 of 1
fda.gov/drugs/drug-safety-communications/fda-requests-removal-suicidal-behavior-and-ideation-warning-glucagon-peptide-1-receptor-agonist-glp8 of 8
fda.gov/drugs/drug-safety-communications/update-fdas-ongoing-evaluation-reports-suicidal-thoughts-or-actions-patients-taking-certain-type2 of 2
fda.gov/drugs/drug-shortages/frequently-asked-questions-about-drug-shortages2 of 2
fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers8 of 8
fda.gov/drugs/human-drug-compounding/fda-alerts-health-care-providers-compounders-and-patients-dosing-errors-associated-compounded11 of 11
fda.gov/drugs/human-drug-compounding/fda-telehealth-companies-what-know-when-promoting-compounded-drugs3 of 3
fda.gov/drugs/human-drug-compounding/information-outsourcing-facilities2 of 2
fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities1 of 1
fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss1 of 1
fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/medicamentos-que-contienen-semaglutida-comercializados-para-la-diabetes-de-tipo-2-o-la-perdida-de1 of 1
fda.gov/food/nutrition-education-resources-materials/sodium-your-diet3 of 3
fda.gov/food/nutrition-food-labeling-and-critical-foods/structurefunction-claims1 of 1
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/online-advisory-letters6 of 6
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/about-warning-and-close-out-letters1 of 1
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/amazoncom-inc-662503-122020231 of 1
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/aspen-aesthetics-dba-fifty-410-721481-022020263 of 3
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/belle-health-llc-dba-belle-721795-022020262 of 2
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/cvs-health-663246-091120231 of 1
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/eden-health-international-inc-dba-eden-728279-060820265 of 5
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/fitrx-llc-dba-am-rx-728275-060820262 of 2
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/fitrx-llc-dba-fitrx-717987-022020262 of 2
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/fitrx-llc-dba-zealthy-716501-090920253 of 3
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/formpour-722215-033120263 of 3
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/hims-hers-health-inc-dba-hers-716825-090920251 of 1
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/hims-hers-health-inc-dba-hims-716567-090920254 of 4
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ivim-services-llc-dba-ivim-721816-022020262 of 2
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/lean-rx-inc-dba-skinnyrx-717989-022020264 of 4
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/levity-inc-dba-levity-717990-022020263 of 3
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/maximus-health-inc-dba-maximus-730095-060820263 of 3
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/medvi-llc-dba-medvi-721455-022020264 of 4
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/orderlymeds-llc-dba-orderlymeds-728291-060820263 of 3
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/prorx-llc-723704-040720262 of 2
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/remedy-meds-716830-090920253 of 3
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/strut-health-llc-dba-strut-721448-022020265 of 5
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/usapeptidecom-696885-022620253 of 3
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/walgreens-boots-alliance-inc-663404-091120231 of 1
fda.gov/news-events/press-announcements/fda-approves-first-medication-obstructive-sleep-apnea2 of 2
fda.gov/news-events/press-announcements/fda-approves-first-new-molecular-entity-under-national-priority-voucher-program3 of 3
fda.gov/news-events/press-announcements/fda-approves-first-treatment-patients-liver-scarring-due-fatty-liver-disease1 of 1
fda.gov/news-events/press-announcements/fda-approves-fourth-product-under-national-priority-voucher-program-higher-dose-semaglutide3 of 3
fda.gov/news-events/press-announcements/fda-intends-take-action-against-non-fda-approved-glp-1-drugs3 of 3
fda.gov/news-events/press-announcements/fda-launches-green-list-protect-americans-illegal-imported-glp-1-drug-ingredients1 of 1
fda.gov/news-events/press-announcements/fda-proposes-exclude-semaglutide-tirzepatide-and-liraglutide-503b-bulks-list3 of 3
fda.gov/news-events/press-announcements/fda-warns-30-telehealth-companies-against-illegal-marketing-compounded-glp-1s5 of 5
federalregister.gov/documents/2024/12/10/2024-27939/medicare-and-medicaid-programs-contract-year-2026-policy-and-technical-changes-to-the-medicare-advantage-program2 of 2
fellahealth.com/3 of 3
fellahealth.com/affiliate-program1 of 1
fellahealth.com/faq1 of 1
fellahealth.com/faq/insurance1 of 1
fellahealth.com/faq/popular-questions2 of 2
fellahealth.com/guarantee3 of 3
fellahealth.com/membership-terms4 of 4
fellahealth.com/treatments2 of 2
fellahealth.com/your-plan6 of 6
fepblue.org/faqs/faq-pharmacy8 of 8
fepblue.org/manage-your-health/managing-specific-conditions/weight1 of 1
fepblue.org/pharmacy/prescriptions3 of 3
fifty410.com/2 of 2
fifty410.com/faq2 of 2
fifty410.com/pricing7 of 7
fifty410.com/refund-policy1 of 1
floridablue.com/answers/all-about-care/understanding-your-prescription-drug-coverage2 of 2
floridablue.com/medicare/education/part-d1 of 1
floridablue.com/members/tools-resources/faq/pharmacy-faqs1 of 1
floridablue.com/members/tools-resources/pharmacy/medication-guide1 of 1
floridablue.com/providers/news/bulletins-and-faqs1 of 1
flsenate.gov/Session/Bill/2025/6482 of 2
formhealth.co/faqs16 of 16
formhealth.co/legal/terms-of-use3 of 3
formhealth.co/weight-loss-medications2 of 2
forwardhealth.wi.gov/WIPortal/Subsystem/KW/Print.aspx?c=11&ia=1&p=1&s=3&sa=481 of 1
forwardhealth.wi.gov/WIPortal/Subsystem/KW/Print.aspx?c=345&ia=1&p=1&s=3&sa=482 of 2
forwardhealth.wi.gov/WIPortal/Subsystem/KW/Print.aspx?ia=1&p=1&sa=48&s=3&c=11&nt=Wegovy+Injection+and+Wegovy+Tablets&adv=Y3 of 3
forwardhealth.wi.gov/WIPortal/Subsystem/KW/Print.aspx?ia=1&p=1&sa=48&s=3&c=345&nt=Weight+Management+Agents&adv=Y4 of 4
ftc.gov/business-guidance/advertising-marketing/health-claims1 of 1
ftc.gov/business-guidance/resources/ftcs-endorsement-guides-what-people-are-asking8 of 8
ftc.gov/business-guidance/resources/gut-check-reference-guide-media-spotting-false-weight-loss-claims2 of 2
ftc.gov/news-events/news/press-releases/2024/08/federal-trade-commission-announces-final-rule-banning-fake-reviews-testimonials3 of 3
gc.nh.gov/bill_status/legacy/bs2016/bill_docket.aspx?lsr=2204&sy=2026&sortoption=&txtsessionyear=2026&txtbillnumber=SB4551 of 1
gc.nh.gov/bill_status/legacy/bs2016/billText.aspx?sy=2026&id=1403&txtFormat=html1 of 1
getzealthy.com/1 of 1
getzealthy.com/faqs1 of 1
getzealthy.com/subscriptions-cancellations-refunds-policy2 of 2
getzealthy.com/weight-loss-faq7 of 7
gimme.care/9 of 9
gimme.care/policies/refund-policy3 of 3
gimme.care/policies/terms-of-service1 of 1
glp1.medvi.org/6 of 6
go.getzealthy.com/zealthy-weight-loss-pricing_homepage/4 of 4
gobymeds.com/11 of 11
gobymeds.com/getting-started/pricing9 of 9
gov.uk/government/news/mhra-finds-evidence-does-not-support-a-link-between-glucagon-like-peptide-1-glp-1-receptor-agonists-and-suicidal-and-self-injurious-thoughts-and-act2 of 2
hca.nm.gov/preferred-drug-list/1 of 1
hca.nm.gov/weight-reduction-medications/5 of 5
hca.wa.gov/billers-providers-partners/program-information-providers/apple-health-medicaid-drug-coverage-criteria3 of 3
hcpf.colorado.gov/pharmacy-benefits2 of 2
hcpf.colorado.gov/pharmacy-billing-manual2 of 2
health.alaska.gov/en/education/prior-authorization-medication/1 of 1
health.amazon.com/onemedical/public/weight-loss/glp-1-weight-loss4 of 4
health.maryland.gov/mmcp/pap/pages/clinical-criteria.aspx1 of 1
health.maryland.gov/mmcp/pap/Pages/paphome.aspx1 of 1
health.maryland.gov/mmcp/provider/_api/web/lists/GetByTitle('Provider-Transmittals')/items?$top=50003 of 3
health.ny.gov/health_care/medicaid/program/update/2025/no01_2025-01.htm3 of 3
health.ny.gov/health_care/medicaid/program/update/2025/no04_2025-04.htm1 of 1
health.ny.gov/health_care/medicaid/redesign/mrt2/pharmacy_transition/pharmacy_transition_faq.htm1 of 1
health.wyo.gov/healthcarefin/medicaid/pharmacy-services/medicaidpharmacy/1 of 1
healthandwelfare.idaho.gov/providers/pharmacy-providers/idaho-medicaid-pharmacy-program1 of 1
healthcare.gov/appeal-insurance-company-decision/external-review/3 of 3
healthcare.gov/appeal-insurance-company-decision/internal-appeals/4 of 4
healthcare.gov/choose-a-plan/comparing-plans/2 of 2
healthcare.gov/coverage/what-marketplace-plans-cover/3 of 3
healthcare.gov/glossary/appeal/2 of 2
healthcare.gov/glossary/brand-name-drugs/1 of 1
healthcare.gov/glossary/co-insurance/2 of 2
healthcare.gov/glossary/co-payment/2 of 2
healthcare.gov/glossary/deductible/2 of 2
healthcare.gov/glossary/external-review/1 of 1
healthcare.gov/glossary/flexible-spending-account-fsa/1 of 1
healthcare.gov/glossary/formulary/1 of 1
healthcare.gov/glossary/generic-drugs/1 of 1
healthcare.gov/glossary/health-savings-account-hsa/1 of 1
healthcare.gov/glossary/out-of-pocket-maximum-limit/2 of 2
healthcare.gov/glossary/preauthorization/1 of 1
healthcare.gov/glossary/prescription-drug-coverage/1 of 1
healthcare.gov/glossary/prescription-drugs/1 of 1
healthcare.gov/glossary/prior-authorization/1 of 1
healthcare.gov/using-marketplace-coverage/prescription-medications/2 of 2
healthy.kaiserpermanente.org/health-wellness/drug-formulary/how-it-works4 of 4
healthy.kaiserpermanente.org/health-wellness/health-encyclopedia/he.weight-loss-medicines.abq51862 of 2
helloalpha.com/membership5 of 5
helloalpha.com/prescription-philosophy2 of 2
helloalpha.com/terms2 of 2
helloalpha.com/weight-loss8 of 8
help.9am.health/api/v2/help_center/en-us/articles/14125762984603.json1 of 1
help.9am.health/api/v2/help_center/en-us/articles/32333170418459.json1 of 1
help.9am.health/api/v2/help_center/en-us/articles/4415328668443.json1 of 1
help.fifty410.com/en/articles/10249499-states-we-cover1 of 1
help.formhealth.co/article/256-id-like-to-cancel-pause-my-account2 of 2
help.formhealth.co/article/32-why-do-i-owe-an-additional-balance-when-i-already-pay-99-month2 of 2
help.formhealth.co/article/482-do-you-prescribe-compounded-medication1 of 1
help.formhealth.co/article/484-are-there-any-clinicians-in-my-area1 of 1
help.invigormedical.com/en/articles/9294008-can-i-cancel-my-subscription-at-any-time3 of 3
help.invigormedical.com/en/articles/9294023-do-you-accept-medical-insurance1 of 1
help.invigormedical.com/en/articles/9294098-do-you-ship-to-other-countries2 of 2
help.invigormedical.com/en/articles/9295011-will-my-subscription-automatically-renew1 of 1
help.invigormedical.com/en/articles/9312241-can-i-clarify-the-cost-of-a-medication-or-treatment-that-i-ordered1 of 1
help.invigormedical.com/en/articles/9319373-i-have-a-question-about-the-medication2 of 2
help.joinbelle.com/en/articles/16648666-does-belle-ship-outside-the-united-states1 of 1
help.joinbelle.com/en/articles/16648678-glp-1-plans-shipments-and-billing-how-it-works1 of 1
help.joinpolly.com/en/articles/14718584-is-there-a-membership-fee1 of 1
help.joinpolly.com/en/articles/14718601-do-the-multi-month-plans-bill-monthly-or-upfront-and-are-they-refundable2 of 2
help.joinpolly.com/en/articles/14718608-what-is-your-monthly-dose-change-price-for-compounded-semaglutide2 of 2
help.joinpolly.com/en/articles/14718621-what-is-your-monthly-dose-change-price-for-compounded-tirzepatide2 of 2
help.remedymeds.com/en/categories/568641-billing1 of 1
help.senate.gov/dem/newsroom/press/news-chairman-sanders-launches-investigation-into-outrageously-high-price-of-ozempic-and-wegovy-in-the-united-states1 of 1
help.sesamecare.com/api/v2/help_center/en-us/articles/40165221309716.json4 of 4
henrymeds.com/faq2 of 2
henrymeds.com/landing/glp-11 of 1
henrymeds.com/treatments/weight-management/glp-1-weight-management6 of 6
henrymeds.com/treatments/weight-management/semaglutide3 of 3
henrymeds.com/treatments/weight-management/tirzepatide-tablets1 of 1
hfs.illinois.gov/medicalproviders/notices/notice.prn260521b.html4 of 4
hfs.illinois.gov/medicalproviders/notices/notice.prn260910a.html7 of 7
hfs.illinois.gov/medicalproviders/pharmacy.html1 of 1
hhs.iowa.gov/medicaid/provider-services/medicaid-pharmacy2 of 2
hhs.nd.gov/healthcare/medicaid/provider/communications/newsletters/nd-medicaid-provider-newsletter-december-20231 of 1
hhs.nd.gov/healthcare/medicaid/provider/communications/newsletters/nd-medicaid-provider-newsletter-june-20241 of 1
hhs.nd.gov/medicaid-member-engagement/news2 of 2
highmark.com/employer/thought-leadership/health-insurance-cost-management/noom-weight-management1 of 1
highmark.com/member/bcbs/medical-drug-formulary4 of 4
hims.com/weight-loss11 of 11
hioscar.com/for-members1 of 1
hioscar.com/for-providers/clinical-guidelines/pharmacy9 of 9
home.medvi.org/3 of 3
home.medvi.org/cancellation-and-refund-policy4 of 4
home.medvi.org/terms-and-conditions2 of 2
honehealth.com/liraglutide/3 of 3
honehealth.com/mens/weight-loss/5 of 5
honehealth.com/terms/4 of 4
house.mn.gov/SessionDaily/Story/190333 of 3
humana.com/medicare/medicare-resources/does-medicare-cover-weight-loss-drugs9 of 9
humana.com/pharmacy/medicare-drug-list2 of 2
humanservices.arkansas.gov/divisions-shared-services/medical-services/1 of 1
huskyhealthct.org/providers/provider_updates.html5 of 5
ibx.com/get-care/prescription-drug-information/find-a-covered-prescription-drug.html2 of 2
ilga.gov/commission/jcar/admincode/089/089001400D04410R.html1 of 1
in.gov/medicaid/members/member-programs/pharmacy-benefits/1 of 1
in.gov/medicaid/providers/clinical-services/pharmacy-benefits/1 of 1
in.gov/medicaid/providers/provider-references/bulletins-banner-pages-and-reference-modules/ihcp-bulletins/1 of 1
investor.lilly.com/news-releases/news-release-details/lilly-launches-additional-zepbound-vial-doses-and-offers-new3 of 3
investor.lilly.com/news-releases/news-release-details/lilly-lowers-price-zepboundr-tirzepatide-single-dose-vials1 of 1
investors.cvshealth.com/news/news-details/2025/CVS-HEALTH-CORPORATION-REPORTS-FIRST-QUARTER-2025-RESULTS-AND-UPDATES-FULL-YEAR-2025-GUIDANCE/default.aspx2 of 2
investors.hims.com/news/news-details/2026/Hims--Hers-Announces-Strategic-Shift-for-US-Weight-Loss-Business/default.aspx2 of 2
iowamedicaidpdl.com/pa-pdl/pa-forms.html1 of 1
irs.gov/individuals/frequently-asked-questions-about-medical-expenses-related-to-nutrition-wellness-and-general-health2 of 2
irs.gov/publications/p5026 of 6
irs.gov/publications/p9692 of 2
irs.gov/taxtopics/tc5021 of 1
ivimhealth.com/1 of 1
ivimhealth.com/glp1idwt/4 of 4
ivimhealth.com/refund_returns/1 of 1
ivimhealth.com/terms-and-conditions/3 of 3
ivimhealth.com/wegovypill/4 of 4
ivimhealth.com/zepbound/1 of 1
ivyrx.com/products/mounjaro1 of 1
ivyrx.com/products/ozempic1 of 1
ivyrx.com/products/personalized-glp-1-injections3 of 3
ivyrx.com/terms-of-service1 of 1
ivyrx.com/weight-loss1 of 1
join9am.com/amazon2 of 2
join9am.com/for-individuals3 of 3
join9am.com/metformin3 of 3
join9am.com/terms-of-service2 of 2
joinamble.com/faq4 of 4
joinamble.com/glp-1-injections5 of 5
joinamble.com/terms-of-service4 of 4
joinbelle.com/faq3 of 3
joinbelle.com/treatments/weight-loss/compounded-semaglutide1 of 1
joincalibrate.com/faqs4 of 4
joincalibrate.com/legal/guarantee6 of 6
joincalibrate.com/legal/membership-terms-and-conditions7 of 7
joincalibrate.com/pricing14 of 14
joinfound.com2 of 2
joinfound.com/glp1-checker1 of 1
joinfound.com/plans-and-pricing9 of 9
joinfound.com/program2 of 2
joinfound.com/terms/offer-terms-v315 of 15
joinfound.com/terms/terms-and-conditions8 of 8
joinfridays.com/faqs5 of 5
joinfridays.com/pricing7 of 7
joinfridays.com/terms-conditions5 of 5
joinfridays.com/1 of 1
joinlevity.com/4 of 4
joinlevity.com/service-unavailable5 of 5
joinlevity.com/terms1 of 1
joinmidi.com/glp1-pricing7 of 7
joinmidi.com/post/midi-glp-1-programs2 of 2
joinmidi.com/pricing-insurance5 of 5
joinmidi.com/weight-management7 of 7
joinmidi.zendesk.com/api/v2/help_center/en-us/articles/15401784783643.json1 of 1
joinmidi.zendesk.com/api/v2/help_center/en-us/articles/15406722476059.json1 of 1
joinmidi.zendesk.com/api/v2/help_center/en-us/articles/15802731388187.json1 of 1
joinmidi.zendesk.com/api/v2/help_center/en-us/articles/27718928834587.json1 of 1
joinmidi.zendesk.com/api/v2/help_center/en-us/articles/27719045385499.json1 of 1
joinmidi.zendesk.com/api/v2/help_center/en-us/articles/27719192737947.json1 of 1
joinmidi.zendesk.com/api/v2/help_center/en-us/articles/28699471228699.json1 of 1
joinmidi.zendesk.com/api/v2/help_center/en-us/articles/28699496854683.json1 of 1
joinmidi.zendesk.com/api/v2/help_center/en-us/articles/29035803201307.json1 of 1
joinmochi.com/faqs8 of 8
joinmochi.com/medications/foundayo1 of 1
joinmochi.com/medications/zepbound1 of 1
joinmochi.com/termsandconditions5 of 5
joinpolly.com/5 of 5
joinpolly.com/refund-policy2 of 2
joinpomegranate.com/faqs1 of 1
joinpomegranate.com/products/compounded-semaglutide4 of 4
joinpomegranate.com/products/compounded-tirzepatide1 of 1
joinpomegranate.com/products/wegovy-r-semaglutide-oral2 of 2
joinpomegranate.com/services/weight-loss1 of 1
joinpomegranate.com/subscription-terms4 of 4
joinpomegranate.com/terms-of-service1 of 1
kdhe.ks.gov/1762/Class-Specific-Clinical-Criteria4 of 4
kdhe.ks.gov/188/Pharmacy1 of 1
kff.org/health-costs/2025-employer-health-benefits-survey/11 of 11
kff.org/health-costs/annual-family-premiums-for-employer-coverage-rise-6-in-2025-nearing-27000-with-workers-paying-6850-toward-premiums-out-of-their-paychecks/2 of 2
kff.org/health-costs/kff-health-tracking-poll-may-2024-the-publics-use-and-views-of-glp-1-drugs/2 of 2
kff.org/public-opinion/kff-health-tracking-poll-prescription-drug-costs-views-on-trump-administration-actions-and-glp-1-use/11 of 11
knownwell.co/faqs19 of 19
knownwell.co/weight-loss-medication-pricing10 of 10
kyportal.medimpact.com/provider-documents/drug-information2 of 2
kyportal.medimpact.com/provider-documents/pharmacy-memos-and-newsletters1 of 1
lamedicaid.com/provweb1/pharmacy/pharmacyindex.htm2 of 2
lao.ca.gov/Publications/Report/50753 of 3
lao.ca.gov/Publications/Report/51461 of 1
laskerfoundation.org/winners/glp-1-based-therapy-for-obesity/10 of 10
lavenderskyhealth.com/faq/2 of 2
lavenderskyhealth.com/service-pricing-lavender-sky-health/5 of 5
lavenderskyhealth.com/treatment-plan-pricing/10 of 10
ldh.la.gov/medicaid/managed-care-pharmacy-and-medical-drug-policies-archive-20251 of 1
ldh.la.gov/medicaid/medicaid-services2 of 2
leg.state.nv.us/App/NELIS/REL/83rd2025/Bill/FillSelectedBillTab?selectedTab=Overview&billKey=123663 of 3
legis.la.gov/legis/BillInfo.aspx?s=26RS&b=SB433&sbi=y2 of 2
legislature.mi.gov/documents/2025-2026/publicact/htm/2025-PA-0022.htm3 of 3
legislature.mi.gov/documents/2025-2026/publicact/htm/2026-PA-0021.htm2 of 2
legislature.vermont.gov/bill/status/2024/H.7651 of 1
lemmelive.com/pages/faq1 of 1
lemmelive.com/products/lemme-glp-19 of 9
lemonaidhealth.com/legals/cancellation-policy1 of 1
lemonaidhealth.com/legals/refund-policy1 of 1
lemonaidhealth.com/services/weight-loss12 of 12
lifemd.com/faq/2 of 2
lifemd.com/terms1 of 1
lifemd.com/weight-management/13 of 13
liferx.md/returns-policy1 of 1
liferx.md/terms-of-use2 of 2
liferx.md/weight-loss7 of 7
lillycares.com/available-medications2 of 2
mainecarepdl.org/content/mainecarepdl/en/prior-authorization-forms.html1 of 1
maximustribe.com/glp-1/wegovy-tablets1 of 1
maximustribe.com/terms-of-use1 of 1
maximustribe.com/weight-loss10 of 10
maximustribe.com/weight-loss/semaglutide-standard1 of 1
maximustribe.com/weight-loss/tirzepatide-standard4 of 4
medicaid.alabama.gov/alert_detail.aspx?ID=167653 of 3
medicaid.alabama.gov/alert_detail.aspx?ID=168072 of 2
medicaid.alabama.gov/content/12.0_Archive/alert_detail_archived.aspx?ID=166743 of 3
medicaid.alabama.gov/content/4.0_Programs/4.3_Pharmacy-DME/4.3.7_Preferred_Drug_List.aspx1 of 1
medicaid.georgia.gov/https:/dch.georgia.gov/providers/medicaid-pharmacy1 of 1
medicaid.ms.gov/ms-spa-23-0013-drugs-to-treat-obesity-approved-by-cms/2 of 2
medicaid.ms.gov/pharmacy-prior-authorization/3 of 3
medicaid.ms.gov/preferred-drug-list-2/5 of 5
medicaid.ncdhhs.gov/blog/2025/09/05/nc-medicaid-change-coverage-glp-1-weight-management-medications3 of 3
medicaid.ncdhhs.gov/blog/2025/12/19/nc-medicaid-reinstitute-coverage-glp-1s-weight-management9 of 9
medicaid.utah.gov/pharmacy-program/prior-authorization/2 of 2
medicaidprovider.mt.gov/191 of 1
medicaidprovider.mt.gov/manuals/prescriptiondrugprogrammanual2 of 2
medicare.gov/coverage/weight-loss-drugs14 of 14
medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work6 of 6
medicare.premera.com/medicare-advantage/1 of 1
medlineplus.gov/clinicaltrials.html3 of 3
medlineplus.gov/druginfo/meds/a618008.html1 of 1
medlineplus.gov/ency/article/000158.htm1 of 1
medlineplus.gov/ency/article/002467.htm2 of 2
medlineplus.gov/ency/article/003088.htm6 of 6
medlineplus.gov/ency/article/003117.htm1 of 1
medlineplus.gov/ency/article/003246.htm6 of 6
medlineplus.gov/ency/patientinstructions/000120.htm6 of 6
medlineplus.gov/ency/patientinstructions/000121.htm5 of 5
medlineplus.gov/ency/patientinstructions/000122.htm6 of 6
medquest.hawaii.gov/en/plans-providers/pharmacy/drug-coverage.html1 of 1
medquest.hawaii.gov/en/plans-providers/pharmacy/drug-coverage/pa-criteria.html1 of 1
medvidi.com/1 of 1
medvidi.com/about-us/refund-policy/2 of 2
medvidi.com/blog/how-to-get-wegovy2 of 2
medvidi.com/faqs/2 of 2
medvidi.com/services/weight-loss-treatment/6 of 6
member.carefirst.com/members/drug-pharmacy-information/drug-search.page1 of 1
mgaleg.maryland.gov/mgawebsite/Legislation/Details/sb0496?ys=2026RS2 of 2
mhdl.pharmacy.services.conduent.com/MHDL/pubintro.do?category=Introduction+to+MassHealth+Drug+List1 of 1
mhdl.pharmacy.services.conduent.com/MHDL/pubtheradetail.do?id=264 of 4
mhdl.pharmacy.services.conduent.com/MHDL/pubtheradetail.do?id=3085&drugId=86717 of 7
michigan.gov/mdhhs/doing-business/providers/providers/billingreimbursement/pharmacy1 of 1
michigan.gov/mdhhs/doing-business/providers/providers/medicaid/policyforms/2025-medicaid-provider-l-letters1 of 1
militaryrx.express-scripts.com/blog/changes-your-tricare-pharmacy-benefit5 of 5
militaryrx.express-scripts.com/blog/how-do-i-know-if-my-medication-covered-tricare1 of 1
militaryrx.express-scripts.com/faq/GLP-1-medications-diabetes-weight-management7 of 7
mn.gov/dhs/partners-and-providers/policies-procedures/minnesota-health-care-programs/provider/types/rx/pa-criteria/anti-obesity-medications.jsp4 of 4
my-bmi.co.uk/4 of 4
my-bmi.co.uk/about-us1 of 1
my-bmi.co.uk/delivery3 of 3
my-bmi.co.uk/wegovy/wegovy-prices3 of 3
nature.com/articles/s41586-026-10940-712 of 12
nccih.nih.gov/health/berberine-and-weight-loss-what-you-need-to-know6 of 6
nccih.nih.gov/health/in-the-news-berberine1 of 1
ndlegis.gov/assembly/69-2025/regular/bill-overview/bo1451.html2 of 2
nebraska.fhsc.com/priorauth/paforms.asp1 of 1
nevadamedicaid.nv.gov/1 of 1
news.gallup.com/poll/712157/glp-usage-reaches-new-high.aspx4 of 4
news.hims.com/newsroom/full-range-of-fda-approved-glp-1s-available-on-hims-hers1 of 1
news.hims.com/newsroom/hims-hers-introduces-6-month-wegovy-r-new-customer-offer2 of 2
news.hims.com/newsroom/wegovy-r-pill-and-wegovy-r-pen-now-available-with-hims-hers10 of 10
news.iu.edu/kinseyinstitute/live/news/46263-survey-shows-glp-1-weight-loss-drugs-are-changing6 of 6
newsroom.cigna.com/all-stories?item=5622 of 2
newsroom.cigna.com/all-stories?item=6893 of 3
nhmmis.nh.gov/portals/wps/portal/MessagesAnnouncementsForPublic2 of 2
nia.nih.gov/health/clinical-trials-and-studies/what-are-clinical-trials-and-studies15 of 15
niaaa.nih.gov/alcohols-effects-health/alcohols-effects-body1 of 1
niaaa.nih.gov/news-events/spectrum/volume-16-issue-1-winter-2024/semaglutide-shows-promise-potential-alcohol-use-disorder-medication2 of 2
nichd.nih.gov/health/topics/pcos/conditioninfo2 of 2
nichd.nih.gov/health/topics/pcos/conditioninfo/treatments2 of 2
niddk.nih.gov/health-information/diabetes/overview/preventing-problems/low-blood-glucose-hypoglycemia2 of 2
niddk.nih.gov/health-information/digestive-diseases/constipation/eating-diet-nutrition1 of 1
niddk.nih.gov/health-information/digestive-diseases/constipation/treatment2 of 2
niddk.nih.gov/health-information/digestive-diseases/diarrhea/eating-diet-nutrition2 of 2
niddk.nih.gov/health-information/digestive-diseases/diarrhea/treatment4 of 4
niddk.nih.gov/health-information/digestive-diseases/gas-digestive-tract/symptoms-causes4 of 4
niddk.nih.gov/health-information/digestive-diseases/gas-digestive-tract/treatment3 of 3
niddk.nih.gov/health-information/liver-disease/nafld-nash/definition-facts2 of 2
niddk.nih.gov/health-information/weight-management/adult-overweight-obesity/clinical-trials3 of 3
niddk.nih.gov/health-information/weight-management/healthy-eating-physical-activity-for-life/health-tips-for-adults4 of 4
niddk.nih.gov/health-information/weight-management/prescription-medications-treat-overweight-obesity2 of 2
niddk.nih.gov/news/archive/2021/story-discovery-medications-diabetes-obesity-emerged-research-pancreatic-hormone5 of 5
nj.gov/humanservices/dmahs/news-publications/overview/2 of 2
noom.com/med/glp-1rx/2 of 2
noom.com/med/glp1-microdose/2 of 2
noom.com/med/pricing/7 of 7
noom.com/med/zepbound/1 of 1
noom.com/medicare-bridge/3 of 3
noom.com/support/faqs/programs/2025/10/noom-refund-policy/2 of 2
noom.com/support/faqs/programs/noom-med-programs/telehealth-for-branded-meds/2025/10/contacting-a-telehealth-clinician/1 of 1
noom.com/support/faqs/programs/noom-med-programs/telehealth-for-branded-meds/2025/10/how-does-the-telehealth-for-branded-meds-program-work/2 of 2
noom.com/support/faqs/programs/noom-med-programs/telehealth-for-branded-meds/2025/10/labs-in-the-telehealth-for-branded-meds-program/2 of 2
noom.com/support/faqs/programs/noom-med-programs/telehealth-for-branded-meds/2025/10/telehealth-for-branded-meds-prescriptions/3 of 3
noom.com/support/faqs/subscription-and-billing/2025/10/how-to-cancel-your-noom-subscription-or-trial/2 of 2
noom.com/support/faqs/subscription-and-billing/2025/10/how-to-upgrade-to-noom-med-program/1 of 1
noom.com/support/faqs/subscription-and-billing/2026/04/switching-your-noom-med-program/1 of 1
noom.com/terms-and-conditions-of-use/4 of 4
novocare.com/diabetes/help-with-costs/pap.html11 of 11
novocare.com/diabetes/products/ozempic.html1 of 1
novocare.com/diabetes/products/ozempic/savings-offer.html1 of 1
novocare.com/eligibility/diabetes-savings-card.html9 of 9
novocare.com/eligibility/pharmacy.html7 of 7
novocare.com/eligibility/wegovy-savings-card.html14 of 14
novocare.com/obesity/products/saxenda.html3 of 3
novocare.com/patient/medicines/wegovy.html1 of 1
novocare.com/patient/medicines/wegovy/savings-offer.html4 of 4
novocare.com/patient/treatment/find-doctor.html1 of 1
novocare.com/pharmacy/faqs.html4 of 4
novocare.com/pharmacy/ozempic.html4 of 4
novocare.com/pharmacy/wegovy.html18 of 18
novomedlink.com/semaglutide/patient-safety/semaglutide-faq.html1 of 1
novonordisk-us.com/media/news-archive/news-details.html?id=9164603 of 3
novonordisk-us.com/media/news-archive/news-details.html?id=9164761 of 1
novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=9163481 of 1
novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=9164163 of 3
novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=9164501 of 1
novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=9164724 of 4
novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=9165011 of 1
novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=9165122 of 2
novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=9165422 of 2
novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=9167656 of 6
novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=9167743 of 3
novonordisk.com/investors/financial-results.html1 of 1
oklahoma.gov/ohca/policies-and-rules/xpolicy/medical-providers-fee-for-service/individual-providers-and-specialties/pharmacies/drug-benefit.html1 of 1
oklahoma.gov/ohca/providers/types/pharmacy/prior-authorization/2026.html1 of 1
oklahoma.gov/ohca/providers/types/pharmacy/prior-authorization/2026/endocrine-diabeticse.html2 of 2
oklahoma.gov/ohca/providers/types/pharmacy/prior-authorization/2026/metabolic-disorders.html5 of 5
olis.oregonlegislature.gov/liz/2025R1/Measures/Overview/HB35172 of 2
onlinesemaglutide.org/1 of 1
opm.gov/healthcare-insurance/healthcare/plan-information/plans/BrochureJson?brochureNumber=71-005&year=20261 of 1
orderlymeds.com/2 of 2
orderlymeds.com/faqs/6 of 6
orderlymeds.com/pricing/4 of 4
orpdl.org/drugs/drugclass.php?cid=10312 of 2
orpdl.org/drugs/drugclass.php?cid=10573 of 3
ozempic.com/2 of 2
ozempic.com/faqs/ozempic-pen.html2 of 2
ozempic.com/ozempic-pen/dosing.html1 of 1
ozempic.com/ozempic-pill/dosing.html1 of 1
ozempic.com/savings-and-resources/save-on-ozempic.html3 of 3
pa.gov/agencies/dhs/departments-offices/omap-info/whats-new-at-omap1 of 1
pacodeandbulletin.gov/Display/pabull?file=/secure/pabulletin/data/vol55/55-52/1777.html7 of 7
pharmacy.amazon.com/dp/B09C947KVF2 of 2
pharmacy.amazon.com/dp/B0B3RQZKKJ1 of 1
pharmacy.amazon.com/dp/B0GD5CK3JN3 of 3
pharmacy.amazon.com/dp/B0GP27N9T33 of 3
pharmacy.amazon.com/dp/B0GVPXYFHV2 of 2
pharmacy.amazon.com/medicare-glp-1-bridge-program-details2 of 2
plushcare.com/how-it-works7 of 7
plushcare.com/membership2 of 2
plushcare.com/refund-policy2 of 2
plushcare.com/semaglutide-prescription1 of 1
plushcare.com/terms3 of 3
plushcare.com/wegovy-semaglutide-prescription2 of 2
plushcare.com/weight-loss8 of 8
plushcare.com/zepbound-tirzepatide-prescription2 of 2
pmc.ncbi.nlm.nih.gov/articles/PMC12612741/22 of 22
pmc.ncbi.nlm.nih.gov/articles/PMC12661421/2 of 2
policy.humana.com/news-and-resources/news-press/2023/humana-to-exit-employer-group-commercial-medical-products1 of 1
portal.ct.gov/governor/news/press-releases/2025/05-2025/governor-lamont-signs-declaration-enabling-the-continued-funding-of-medicaid-this-fiscal-year1 of 1
portal.ct.gov/HUSKY/Pharmacy2 of 2
premera.com/wa/employer/news/pharmacy/glp-1-medications/2 of 2
premera.com/wa/provider/news/medical-policies/policy-updates/2 of 2
premera.com/wa/provider/pharmacy/drug-search/rx-search/1 of 1
prnewswire.com/news-releases/lilly-and-us-government-agree-to-expand-access-to-obesity-medicines-to-millions-of-americans-302607652.html2 of 2
prnewswire.com/news-releases/lilly-calls-on-online-platforms-payment-companies-and-regulators-to-shut-down-the-illegal-retatrutide-black-market-302849551.html1 of 1
prnewswire.com/news-releases/lilly-reports-second-quarter-2026-financial-results-raises-full-year-guidance-and-highlights-continued-growth-and-pipeline-progress-302843165.html1 of 1
prnewswire.com/news-releases/lillys-triple-agonist-retatrutide-delivered-powerful-weight-loss-in-pivotal-phase-3-obesity-trial-302778859.html5 of 5
prnewswire.com/news-releases/lillys-triple-agonist-retatrutide-successful-in-two-additional-phase-3-obesity-trials-delivering-significant-improvements-in-weight-and-a1c-302832674.html2 of 2
prnewswire.com/news-releases/novo-nordisk-advances-cardiometabolic-pipeline-with-new-data-featuring-cagrisema-and-zenagamtide-at-the-american-diabetes-associations-2026-scientific-sessions-302783110.html2 of 2
producernews.premera.com/february-premera-formulary-newsletter/6 of 6
producernews.premera.com/give-clients-a-smarter-way-to-manage-glp-1-coverage-for-weight-management/4 of 4
producernews.premera.com/mapping-employer-priorities-to-glp-1-solutions/3 of 3
provcomm.ibx.com/pnc-ibc/news/Pages/Changes-coming-to-weight-loss-drug-coverage-benefits.aspx4 of 4
provcomm.ibx.com/pnc-ibc/news/Pages/IBX-to-end-Commercial-coverage-of-Zepbound-for-OSA.aspx4 of 4
provcomm.ibx.com/pnc-ibc/news/Pages/The-Medicare-GLP-1-Bridge_What-providers-need-to-know-.aspx4 of 4
provider.carefirst.com/providers/news/2023/07/coverage-reminders-for-glucagon-like-peptide-1/2 of 2
provider.carefirst.com/providers/news/2023/12/new-documentation-requirements-for-incretin-mimetics/1 of 1
provider.carefirst.com/providers/news/2025/06/carefirst-formulary-updates-effective-jul-1-2025/1 of 1
providernews.anthem.com/california/articles/weight-management-program-overview-241961 of 1
providernews.anthem.com/virginia/articles/prepare-prescriptions-for-the-medicare-bridge-program-323513 of 3
providers.highmark.com/communications-hub/news-and-updates/clinical-solutions-for-2026-noom-sud-specialty-care-additional-offerings.html2 of 2
providers.highmark.com/communications-hub/news-and-updates/medicare-glp-1-bridge-new-cms-program-for-certain-weight-loss-drugs.html5 of 5
providers.highmark.com/wholecare/wholecare-newsfeed/glp-1-agonist-changes.html1 of 1
pushhealth.com/drugs/glp-1-agonist3 of 3
pushhealth.com/drugs/ozempic1 of 1
pushhealth.com/drugs/zepbound1 of 1
pushhealth.com/pages/faq10 of 10
pushhealth.com/services/weight-loss1 of 1
raeliva.com/about/4 of 4
raeliva.com/faqs/11 of 11
raeliva.com/products/semaglutide-injections/1 of 1
realfood.gov/6 of 6
regs.maryland.gov/us/md/exec/comar/10.09.03.052 of 2
regs.maryland.gov/us/md/exec/comar/10.67.06.272 of 2
regulations.delaware.gov/api/file/download/html/35a18ad4-f4e7-4976-b026-bbac6686281a4 of 4
regulations.delaware.gov/api/register/submissionContent/30%20DE%20Reg%20149%2009-01-265 of 5
regulations.delaware.gov/api/register/submissionContent/30%20DE%20Reg%2015%2007-01-261 of 1
remedymeds.com/6 of 6
remedymeds.com/legal/terms-of-service7 of 7
remedymeds.com/medication/comp-sema-inj3 of 3
remedymeds.com/medication/comp-tirz-inj1 of 1
revisor.mn.gov/bills/94/2026/0/HF/4142/?body=house1 of 1
revisor.mn.gov/bills/94/2026/0/HF/4142/versions/0/1 of 1
revisor.mn.gov/statutes/cite/256B.06253 of 3
rilegislature.gov/pressrelease/_layouts/15/ril.pressrelease.inputform/DisplayForm.aspx?List=c8baae31-3c10-431c-8dcd-9dbbe21ce3e9&ID=3767211 of 1
ro.co/faq/cost-pricing-services/1 of 1
ro.co/returns-and-refunds/1 of 1
ro.co/terms-of-use/15 of 15
ro.co/weight-loss/2 of 2
ro.co/weight-loss/insurance/2 of 2
ro.co/weight-loss/pricing/18 of 18
rx.costco.com/member-value-pricing3 of 3
saxenda.com/1 of 1
scdhhs.gov/providers/pharmacy1 of 1
sesamecare.com/blog/costco-half-price-ozempic-wegovy3 of 3
sesamecare.com/blog/sesame-weight-loss-announcement3 of 3
sesamecare.com/join/sc2024-membership-perks1 of 1
sesamecare.com/medication/semaglutide1 of 1
sesamecare.com/service/online-weight-loss-program28 of 28
sesamecare.com/terms-of-service6 of 6
shop.joinmidi.com/products/daily-glp-1-support1 of 1
skinnyrx.com/blog/skinnyrx-vs-ro-glp-1-weightloss8 of 8
skinnyrx.com/terms8 of 8
southcarolina.fhsc.com/providers/documents.asp1 of 1
southcarolinablues.com/en/home/blog/categories/health-care-insurance-101/2024/pharmacy-benefits-explained.html1 of 1
southcarolinablues.com/en/home/members/prescription-drugs/medicare-advantage-and-prescription-drug-plans--pdp-.html1 of 1
southcarolinablues.com/en/home/members/prescription-drugs/other-group-plans.html2 of 2
southcarolinablues.com/en/home/providers/news-and-events/news-bulletins/commercial-glp-1-coverage-updates-for-expanded-fda-approved-indi.html8 of 8
southcarolinablues.com/en/home/providers/news-and-events/news-bulletins/important-updates-for-glp-1-provider-taxonomy-edits.html2 of 2
southcarolinablues.com/en/home/providers/news-and-events/news-bulletins/reminder--glp-1-utilization-management.html5 of 5
startwillow.com/3 of 3
startwillow.com/compound-semaglutide1 of 1
startwillow.com/compound-tirzepatide1 of 1
startwillow.com/faqs6 of 6
startwillow.com/semaglutide-tablets1 of 1
startwillow.com/tirzepatide-tablets1 of 1
static.cigna.com/assets/chcp/resourceLibrary/coveragePolicies/pharmacy_a-z.html1 of 1
struthealth.com/1 of 1
struthealth.com/faq5 of 5
struthealth.com/mens-weight-loss/injectable-tirzepatide3 of 3
struthealth.com/mens-weight-loss/oral-tirzepatide1 of 1
struthealth.com/weight-loss5 of 5
struthealth.com/weight-loss/semaglutide2 of 2
support.ivyrx.com/en/articles/10085248-general-faqs3 of 3
support.ivyrx.com/en/articles/10094882-semaglutide-weight-loss-program3 of 3
support.ivyrx.com/en/articles/10095356-ozempic1 of 1
support.plushcare.com/api/v2/help_center/en-us/articles/360021492034.json1 of 1
support.plushcare.com/api/v2/help_center/en-us/articles/360021499374.json1 of 1
support.plushcare.com/api/v2/help_center/en-us/articles/360035957554.json2 of 2
support.plushcare.com/api/v2/help_center/en-us/articles/5887584826899.json1 of 1
support.pushhealth.com/article/126-medication-prescriptions2 of 2
thecignagroup.com/about-us/milestones1 of 1
tmhp.com/news/2022-08-26-clinical-prior-authorization-xenical-no-longer-required-after-september-12-20221 of 1
tmhp.com/news/2025-11-21-wegovy-clinical-prior-authorization-new-metabolic-dysfunction-associated1 of 1
tmhp.com/news/2025-11-21-zepbound-clinical-prior-authorization-criteria-guide-updates2 of 2
trumprx.gov/3 of 3
tryeden.com/policies/terms-of-service2 of 2
tryeden.com/treatment/glp-1-treatments5 of 5
tryeden.com/treatment/wegovy2 of 2
tryeden.com/treatment/zepbound1 of 1
tryinvigor.com/2 of 2
tryinvigor.com/plans/glp-1-treatments/3 of 3
trypeak.com/12 of 12
trypeak.com/terms-and-conditions/3 of 3
tryshed.com/7 of 7
tryshed.com/products/compounded-semaglutide-injections3 of 3
tryshed.com/products/compounded-tirzepatide-injections1 of 1
tryshed.com/products/foundayo1 of 1
tryshed.com/products/product/wegovy2 of 2
tryshed.com/products/product/zepbound-shed-membership2 of 2
tryshed.com/resources/legal/terms7 of 7
trytrimi.com/9 of 9
trytrimi.com/refund-policy2 of 2
trytrimi.com/states1 of 1
uhc.com/agents-brokers/employer-sponsored-plans/news-strategies/demand-for-glp-1-drugs1 of 1
uhc.com/member-resources/pharmacy-benefits/aca-marketplace-plans1 of 1
uhc.com/member-resources/pharmacy-benefits/faq1 of 1
uhcprovider.com/en/health-plans-by-state/rhode-island-health-plans/ri-comm-plan-home/ri-cp-pharmacy.html2 of 2
uhcprovider.com/en/prior-auth-advance-notification/prior-auth-specialty-drugs/prior-auth-pharmacy-medical-necessity.html5 of 5
uhcprovider.com/en/resource-library/news/2026/ga-commercial-plan-info.html1 of 1
uhcprovider.com/en/resource-library/news/2026/glp-1-bridge-program.html7 of 7
uhcprovider.com/en/resource-library/news/2026/ma-medicaid-weight-obesity-drug-coverage.html3 of 3
uspl.lilly.com/mounjaro/mounjaro.html1 of 1
vamedicaid.dmas.virginia.gov/bulletin/upcoming-changes-service-authorization-criteria-weight-loss-drugs4 of 4
vamedicaid.dmas.virginia.gov/bulletin/virginia-medicaid-preferred-drug-list-common-core-formulary-and-new-drug-utilization-11 of 1
walgreens.com/topic/virtual-healthcare/weight-loss.jsp18 of 18
webserver.rilegislature.gov/BillText/BillText26/HouseText26/H7127Aaa.htm2 of 2
wegovy.com/2 of 2
wegovy.com/obesity/starting-wegovy/faq.html2 of 2
weightwatchers.com/us/cancellation2 of 2
weightwatchers.com/us/find-my-plan/results/?bundleId=6cb13558-78c9-4eec-ac92-0a0c98b08649&step=31 of 1
weightwatchers.com/us/termsandconditions/ww-clinic8 of 8
weightwatchers.com/us/weight-loss-medication16 of 16
weightwatchers.com/us/weight-loss-medication/foundayo2 of 2
weightwatchers.com/us/weight-loss-medication/wegovy2 of 2
weightwatchers.com/us/weight-loss-medication/wegovy-pill1 of 1
weightwatchers.com/us/weight-loss-medication/zepbound6 of 6
welcome.optumrx.com/tenncare/forms1 of 1
wellcare.com/en/california/providers/bulletins/medicare-glp-1-bridge-program2 of 2
wellcare.com/en/providers/medicare-bulletins/glp-bridge-program-20263 of 3
wellcare.com/en/resources/does-medicare-cover-weight-loss-drugs12 of 12
whitehouse.gov/fact-sheets/2025/11/fact-sheet-president-donald-j-trump-announces-major-developments-in-bringing-most-favored-nation-pricing-to-american-patients/9 of 9
whitehouse.gov/fact-sheets/2026/02/fact-sheet-president-donald-j-trump-launches-trumprx-gov-to-bring-lower-drug-prices-to-american-patients/8 of 8
whitehouse.gov/fact-sheets/2026/08/fact-sheet-president-donald-j-trump-announces-deal-with-nine-additional-pharmaceutical-manufacturers-to-lower-drug-prices-for-americans/1 of 1
whitehouse.gov/fact-sheets/2026/09/fact-sheet-president-donald-j-trump-announces-lower-drug-prices-for-all-50-state-medicaid-programs/1 of 1
whitehouse.gov/releases/2026/02/president-trump-launches-trumprx-gov-delivering-massive-immediate-savings-to-millions-of-americans/3 of 3
whitehouse.gov/releases/2026/09/president-trump-extends-most-favored-nation-pricing-to-every-medicaid-program-in-america/3 of 3
womenshealth.gov/a-z-topics/polycystic-ovary-syndrome3 of 3
wvlegislature.gov/Bill_Status/bills_history.cfm?input=743&year=2024&sessiontype=RS&btype=bill1 of 1

All weekly reports · How we check prices